皮膚科臨床アセット　16　蕁麻疹・血管性浮腫

出版社： 中山書店
著者：
発行日： 2013-02-28
分野： 臨床医学：内科  >  皮膚科
ISBN： 9784521733531
シリーズ： 皮膚科臨床アセット
電子書籍版： 2013-02-28 （初版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

15,950 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

15,950 円(税込)

購入する

商品紹介

蕁麻疹は皮膚科診療において大きな割合を占める日常的な疾患でありながら，その病態は複雑で，臨床経過もさまざま。本書はそのような蕁麻疹を，総論では病態，検査，治療法について詳述し，各論では各病型別に解説。血管性浮腫や色素性蕁麻疹などの蕁麻疹関連疾患も網羅。最新のガイドラインに基づき，蕁麻疹を深く掘り下げて解説した，蕁麻疹診療の心強い味方となる一冊。

目次

  • 皮膚科臨床アセット　16　蕁麻疹・血管性浮腫

    ―目次―

    1．蕁麻疹（総論）
    2．血管性浮腫（総論）
    3．蕁麻疹の病型（各論）
    4．血管性浮腫の病型（各論）
    5．蕁麻疹の類症

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

I 蕁麻疹 ( 総論 )

P.2 掲載の参考文献
1) Maurer M, Weller K, Bindslev-Jensen C, et al. Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report. Allergy 2011 ; 66 : 317-30.
PubMed
2) Ozkan M, Oflaz SB, Kocaman N, et al. Psychiatric morbidity and quality of life in patients with chronic idiopathic urticaria. Ann Allergy Asthma Immunol 2007 ; 99 : 29-33.
PubMed
3) Sheldon J, Mathews K, Lovell R. The vexing urticaria problem : present concepts of etiology and management. J Allergy 1954 ; 25 : 525-60.
PubMed
4) Zuberbier T, Balke M, Worm M, et al. Epidemiology of urticaria : a representative cross-sectional population survey. Clin Exp Dermatol 2010 ; 35 : 869-73.
PubMed
5) Hermann-Kunz E. Haufigkeit allergischer krankenhieten in Ost- und Westdeutschland. Gesundheitswesen 1999 ; 61 : 100-5.
 
6) Kalogeromitros D, Psaltopoulou T, Markris M, et al. Can internet surveys help us understanding allergic disorders? -results from a large survey in urticaria in Greece. J Eur Acad Dermatol Venereol 2011 ; 25 : 532-7.
 
7) Kulthanan K, Jiamton S, Thumpimukvatana N, et al. Chronic idiopathic urticaria : prevalence and clinical course. J Dermatol 2007 ; 34 : 294-301.
PubMed
8) Sabry EY. Prevalence of allergic diseases in a sample of Taif citizens by an original Arabic questionnaire (phase I). A pioneer study in Saudi Arabia. Allergol Immunopathol (Madr) 2011 ; 39 : 96-105.
 
9) Bakke P, Gulsvik A, Eide GE. Hay fever, eczema and urticaria in southwest Norway. Allergy 1990 ; 45 : 515-22.
PubMed
10) Hellgren L. The prevalence of urticarial in the total population. Acta Allergol 1972 ; 27 : 236-40.
PubMed
11) Gaig P, Olona M, Munoz Lejarazu D, et al. Epidemiology of urticaria in Spain. J Invest Allergol Clin Immunol 2004 ; 14 : 214-20.
 
12) Zuberbier T, Althaus C, Chantraine-Hess S, et al. Prevalence of cholinergic urticarial in younger adults. J Am Acad Dermatol 1994 ; 31 : 978-81.
 
13) Konstantinou GN, Papadopoulos NG, Tavladaki T, et al. Childhood acute urticaria in northern and southern Europe shows a similar epidemiological pattern and significant meteorological influences. Pediatr Allergy Immunol 2011 ; 22 : 36-42.
 
14) Mortureux P, Leaute-Labreze C, Legrain-Lifermann V, et al. Acute urticaria in infancy and early childhood : a prospective study. Arch Dermatol 1998 ; 134 : 319-23.
PubMed
15) Isik SR, Karakaya G, Celikel S, et al. Association between asthma and NSAID hypersensitivity in chronic urticaria patients and prevalence rates. Int Arch Allergy Immunol 2009 ; 150 : 299-306.
PubMed
16) Kozel MM, Bossuyt PM, Mekkes JR, et al. Laboratory tests and identified diagnoses in patients with physical and chronic urticaria and angioedema : a systematic review. J Am Acad Dermatol 2003 ; 48 : 409-16.
PubMed
P.6 掲載の参考文献
1) 秀道広, 森田栄伸, 古川福実, ほか. 蕁麻疹診療ガイドライン. 日皮会誌 2011 ; 121 : 1339-88.
 
2) 小豆澤宏明, 片山一朗. 症候としての蕁麻疹-膠原病と症候群. MB Derma 2005 ; 105 : 7-13.
 
3) 亀好良一. 慢性蕁麻疹に検査は必要か? 宮地良樹, ほか編. EBM皮膚疾患の治療 2008-2009. 東京 : 中外医学社 ; 2008. pp57-62.
 
4) 秀道広, 古江増隆, 大路昌孝, ほか. プライマリケア版 蕁麻疹・血管性浮腫の治療ガイドライン. 2007. http://www.jaanet.org/pdf/guideline_skin04.pdf
 
5) 秀道広. じんま疹・肥満細胞腫・色素性じんま疹. 小児科診療 2009 ; 72 : 1987-92.
Medical*Online
6) 高路修. 急性・慢性蕁麻疹とその原因. 玉置邦彦, ほか編. 最新皮膚科学大系 3. 湿疹 痒疹 掻痒症 紅皮症 蕁麻疹. 東京 : 中山書店 ; 2002. pp196-205.
 
7) 秀道広. 膨疹に対する診療手順と症状誘発が可能な蕁麻疹. 日本醫事新報 2004 ; 4193 : 33-6.
 
8) 秀道広. 蕁麻疹の診療. 日皮会誌 2012 ; 122 : 2627-34.
 
9) 秀道広. 血管性浮腫, 蕁麻疹・血管性浮腫の鑑別疾患と見誤りやすい蕁麻疹. 日本醫事新報 2004 ; 4195 : 33-6.
 
10) Jones RR, Bhogal B, Dash A, et al. Urticaria and vasculitis : a continuum of histological and immunopathological changes. Br J Dermatol 1983 ; 108 : 695-703.
PubMed
P.15 掲載の参考文献
1) 秀道広, 古江増隆, 池澤善郎, ほか. 蕁麻疹・血管性浮腫の治療ガイドライン. 日皮会誌 2005 ; 115 : 703-15.
 
2) 秀道広, 森田栄伸, 古川福実, ほか. 蕁麻疹診療ガイドライン. 日皮会誌 2011 ; 121 : 1339-88.
 
3) 矢村卓三, 山崎玲子. 蕁麻疹. 久木田淳, ほか編. 現代皮膚科学大系 13. 湿疹 痒疹 蕁麻疹. 東京 : 中山書店 ; 1980. pp201-76.
 
4) Grattan C, Powell S, Humphreys F. Management and diagnostic guidelines for urticaria and angio-oedema. Br J Dermatol 2001 ; 144 : 708-14.
PubMed
5) Grattan CEH, Humphreys F. Guidelines for evaluation and management of urticaria in adults and children. Br J Dermatol 2007 ; 157 : 1116-23.
PubMed
6) Powell RJ, Du Toit GL, Siddique N, et al. BSACI guidelines for the management of chronic urticaria and angio-oedema. Clin Exp Allergy 2007 ; 37 : 631-50.
PubMed
7) Zuberbier T, Asero R, Blindslev-Jensen C, et al. EAACI/GA2LEN/EGF/WAO guideline : definition, classification and diagnosis of urticaria. Allergy 2009 ; 64 : 1417-26.
 
8) Champion RH. Urticaria : then and now. Br J Dermatol 1988 ; 119 : 427-36.
PubMed
9) Nettis E, Pannofino A, Aprile CD, et al. Clinical and aetiological aspects in urticaria and angio-oedema. Br J Dermatol 2003 ; 148 : 501-6.
 
10) 田中稔彦, 亀好良一, 秀道広. 広島大学皮膚科外来での蕁麻疹の病型別患者数. アレルギー 2006 ; 55 : 134-9.
 
11) Kontou-Fili K, Borici-Mazi R, Kapp A, et al. Physical urticaria : classification and diagnostic guidelines. Allergy 1997 ; 52 : 504-13.
PubMed
12) Magerl M, Borzova E, Gimenez-Arnau A, et al. The definition and diagnostic testing of physical and cholinergic urticarias-EAACI/GA2LEN/EDF/UNEV consensus panel recommendations. Allergy 2009 ; 64 : 1715-21.
PubMed
13) Zuberbier T, Bindslev-Jensen C, Canonica W, et al. EAACI/GA2LEN/EDF guideline : definition, classification and diagnosis of urticaria. Allergy 2006 ; 61 : 316-320.
PubMed
14) Kowalski ML, Makowska JS, Blanca S, et al. Hypersensitivity to nonsteroidal antiinflammatory drugs (NSAIDs) -classification, diagnosis and management : review of the EAACI/ENDA and GA2LEN/HANNA. Allergy 2011 ; 66 : 818-829.
 
P.20 掲載の参考文献
1) 秀道広, 森田栄伸, 古川福実, ほか. 蕁麻疹診療ガイドライン. 日皮会誌 2011 ; 121 : 1339-88.
 
2) 亀好良一, 秀道広. 膨疹とその形成機序. 玉置邦彦, ほか編. 最新皮膚科学大系 3. 湿疹 痒疹 掻痒症 紅皮症 蕁麻疹. 東京 : 中山書店 ; 2002. pp186-95.
 
3) Millikan LE. Papular urticarial. Semin Dermatol 1993 ; 12 : 53-6.
PubMed
4) Gousseff M, Arnoud L, Lambert M, et al. The systemic capillary leak syndrome : a case series of 28 patients from a European registry. Ann Intern Med 2011 ; 154 : 464-71.
 
5) Braun-Falco M, Ruzicka T. Skin manifestations in autoinflammatory syndromes. J Dtsch Dermatol Ges 2011 ; 9 : 232-46.
PubMed
6) 「食物アレルギーの診療の手引き 2011」検討委員会. 厚生労働科学研究班による食物アレルギーの診療の手引き 2011. http://www.foodallergy.jp/manual2011.pdf.
 
P.26 掲載の参考文献
1) de Bes J, Legierse CM, Prinsen CA, et al. Patient education in chronic skin diseases : a systematic review. Acta Derm Venereol 2011 ; 91 : 12-7.
PubMed
2) Baiardini I, Pasquali M, Braido F, et al. A new tool to evaluate the impact of chronic urticaria on quality of life : chronic urticaria quality of life questionnaire (CU-QoL). Allergy 2005 ; 60 : 1073-8.
PubMed
3) REILLY ASSOSIATES. Health Outcomes Reseach. http://www.reillyassociates.net/
 
4) Thompson AK, Finn AF, Schoenwetter WF. Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria. J Am Acad Dermatol 2000 ; 43 : 24-30.
PubMed
5) Pearce DJ, Singh S, Balkrishnan R, et al. The negative impact of psoriasis on the workplace. J Dermatolog Treat 2006 ; 17 : 24-8.
PubMed
6) Murota H, Kitaba S, Tani M, et al. Effects of nonsedative antihistamines on productivity of patients with pruritic skin diseases. Allergy 2010 ; 65 : 929-30.
PubMed
7) Murota H, Kitaba S, Tani M, et al. Impact of sedative and non-sedative antihistamines on the impaired productivity and quality of life in patients with pruritic skin diseases. Allergol Int 2010 ; 59 : 345-54.
PubMed
P.29 掲載の参考文献
1) 森田栄伸. エリテマトーデスの臨床像とメカニズム. 戸倉新樹, 編. ファーストステップ 皮膚免疫学. 東京 : 中外医学社 ; 2010. pp124-30.
 
2) Petersen LJ, Church MK, Skov PS. Histamine is released in the wheal but not the flare following challenge of human skin in vivo : a microdialysis study. Clin Exp Allergy 1997 ; 27 : 284-95.
PubMed
3) 多田富雄, 訳. 免疫学イラストレイテッド. 原書第2版. 東京 : 南江堂 ; 1990. p265.
 
4) 秀道広, 森田栄伸, 古川福実, ほか. 蕁麻疹診療ガイドライン. 日皮会誌 2011 ; 121 : 1339-88.
 
5) 秀道広, 古江増隆, 池澤善郎, ほか. 蕁麻疹・血管性浮腫の治療ガイドライン. 日皮会誌 2005 ; 115 : 703-15.
 
6) 森田栄伸. 肥満細胞と皮膚疾患 蕁麻疹. MB Derma 2006 ; 120 : 41-5.
 
7) 森田栄伸. 病態から考える抗ヒスタミン薬の使い方 蕁麻疹. Progress in Medicine 2007 ; 27 : 1787-91.
 
P.35 掲載の参考文献
1) Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA2LEN/EDF/WAO guideline : definition, classification and diagnosis of urticaria. Allergy 2009 ; 64 : 1417-26.
 
2) Maurer M, Bindslev-Jensen C, Gimenez-Arnau A, et al. Chronic idiopathic urticaria (CIU) is no longer idiopathic : time for an update. Br J Dermatol 2013 ; 168 : 455-6.
PubMed
3) 秀道広, 森田栄伸, 古川福実, ほか. 蕁麻疹診療ガイドライン. 日皮会誌 2011 ; 121 : 1339-88.
 
4) 秀道広. 蕁麻疹-最近の話題. 皮膚病診療 2009 ; 31 : 13-23.
 
5) Metz M, Maurer M. Omalizumab in chronic urticaria. Curr Opin Allergy Clin Immunol 2012 ; 12 : 406-11.
PubMed
P.39 掲載の参考文献
1) Nettis E, Pannofino A, D'Aprile C, et al. Clinical and aetiological aspects in urticaria and angio-oedema. Br J Dermatol 2003 ; 148 : 501-6.
PubMed
2) 秀道広, 森田栄伸, 古川福実, ほか. 蕁麻疹診療ガイドライン. 日皮会誌 2011 ; 121 : 1339-88.
 
3) 海老原香子, 中村稔, 大井綱郎. 塩酸セフォチアムによる接触蕁麻疹症候群の1例. 皮膚臨床 2002 ; 44 : 1401-4.
 
4) 西脇冬子, 藤井秀孝. 染毛剤によるアナフィラキシーショックの2例. 皮膚臨床 2011 ; 53 : 705-8.
 
5) 高路修. 急性・慢性蕁麻疹とその原因. 玉置邦彦, ほか編. 最新皮膚科学大系 3. 湿疹 痒疹 掻痒症 紅皮症 蕁麻疹. 東京 : 中山書店 ; 2002. pp196-205.
 
6) Wedi B, Raap U, Wieczorek D, et al. Urticaria and infections. Allergy Asthma Clin Immunol 2009 ; 5 : 10.
PubMed
7) Hernando-Harder AC, Booken N, Goerdt S, et al. Helicobacter pylori infection and dermatologic diseases. Eur J Dermatol 2009 ; 19 : 431-44.
 
8) Dave ND, Xiang L, Rehm KE, et al. Stress and allergic diseases. Immunol Allergy Clin North Am 2011 ; 31 : 55-68.
PubMed
9) 田中稔彦, 秀道広. 慢性蕁麻疹における自己抗体の意義. 日皮会誌 2009 ; 119 : 2897-9.
 
P.42 掲載の参考文献
1) 秀道広, 森田栄伸, 古川福実, ほか. 蕁麻疹診療ガイドライン. 日皮会誌 2011 ; 121 : 1339-88.
 
2) Baldari U, Raccagni AA, Celli B, et al. Chronic bullous disease of childhood following Epstein-Barr virus seroconversion : a case report. Clin Exp Dermatol 1996 ; 21 : 123-6.
PubMed
3) Kanazawa K, Yaoita H, Tsuda F, et al. Hepatitis C virus infection in patients with urticaria. J Am Acad Dermatol 1996 ; 35 : 195-8.
PubMed
P.45 掲載の参考文献
1) 角田孝彦, 山口雅敏, 青木恵理. 急性感染性蕁麻疹13例の検討. 臨皮 1996 ; 50 : 397-401.
 
2) Sakurai M, Oba M, Matsumoto K, et al. Acute infectious urticaria : clinical and laboratory analysis in nineteen patients. J Dermatol 2000 ; 27 : 87-93.
PubMed
3) 奥野公也, 角田孝彦. 急性感染性蕁麻疹. 臨皮 2007 ; 61 : 34-6.
 
4) 宮田義久, 鈴木民夫. 急性感染性蕁麻疹の10例. 臨皮 2002 ; 56 : 492-4.
 
5) 下山克, 福田眞作. 慢性じんま疹. 日本臨牀 2005 ; 63 : 317-9.
Medical*Online
6) Sakurane M, Shiotani A, Furukawa F. Therapeutic effects of antibacterial treatment for intractable skin diseases in Helicobacter pylori-positive Japanese patients. J Dermatol 2002 ; 29 : 23-7.
PubMed
7) 日本ヘリコバクター学会ガイドライン作成委員会. H. pylori感染の診断と治療のガイドライン 2009 改訂版. 日本ヘリコバクター学会誌 2009 ; 10 (Suppl) ; 1-25.
 
8) Abdou AG, Elshayeb EI, Farag AG, et al. Helicobacter pylori infection in patients with chronic urticaria : correlation with pathologic findings in gastric biopsies. Int J Dermatol 2009 ; 48 : 464-9.
PubMed
9) Federman DG, Kirsner RS, Moriarty JP, et al. The effect of antibiotic therapy for patients infected with Helicobacter pylori who have chronic urticaria. J Am Acad Dermatol 2003 ; 49 : 861-4.
PubMed
P.49 掲載の参考文献
1) Takahagi S, Mihara S, Iwamoto K, et al. Coagulation/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria. Allergy 2010 ; 65 : 649-56.
PubMed
2) Asero R, Tedeschi A, Riboldi P, et al. Plasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes whealand-flare reactions much more frequently than autologous serum. J Allergy Clin Immunol 2006 ; 117 : 1113-7.
 
3) Fujii K, Usuki A, Kan-No Y, et al. Elevation of circulating thrombin-antithrombin III complex and fibrin degradation products in urticaria : a laboratory finding unrelated to intravascular coagulopathy. J Dermatol 2008 ; 35 : 308-10.
PubMed
4) Cugno M, Marzano AV, Tedeschi A, et al. Expression of tissue factor by eosinophils in patients with chronic urticaria. Int Arch Allergy Immunol 2008 ; 148 : 170-4.
PubMed
5) Takeda T, Sakurai Y, Takahagi S, et al. Increase of coagulation potential in chronic spontaneous urticaria. Allergy 2011 ; 66 : 428-33.
PubMed
6) van Geffen M, Cugno M, Lap P, et al. Alterations of coagulation and fibrinolysis in patients with angioedema due to C1-inhibitor deficiency. Clin Exp Immunol 2012 ; 167 : 472-8.
PubMed
P.56 掲載の参考文献
1) Ombrello MJ, Remmers EF, Sun G, et al. Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions. N Engl J Med 2012 ; 366 : 330-8.
PubMed
1) O'Donnell BF, O'Neill CM, Francis DM, et al. Human leucocyte antigen class II associations in chronic idiopathic urticaria. Br J Dermatol 1999 ; 140 : 853-8.
PubMed
2) Oztas P, Onder M, Gonen S, et al. Is there any relationship between human leucocyte antigen class II and chronic urticaria? (chronic urticaria and HLA class II). Yonsei Med J 2004 ; 45 : 392-5.
PubMed
3) Kim SH, Choi JH, Lee KW, et al. The human leucocyte antigen-DRB1*1302-DQB1*0609-DPB1*0201 haplotype may be a strong genetic marker for aspirin-induced urticaria. Clin Exp Allergy 2005 ; 35 : 339-44.
 
4) Coban M, Erdem T, Ozdemir S, et al. HLA class I and class II genotyping in patients with chronic urticaria. Int Arch Allergy Immunol 2008 ; 147 : 135-9.
 
5) Bae JS, Kim SH, Ye YM, et al. Significant association of FcεRIα promoter polymorphisms with aspirin-intolerant chronic urticaria. J Allergy Clin Immunol 2007 ; 119 : 449-56.
 
6) Kim SH, Kang YM, Kim SH, et al. Histamine N-methyltransferase 939A > G polymorphism affects mRNA stability in patients with acetylsalicylic acid-intolerant chronic urticaria. Allergy 2009 ; 64 : 213-21.
PubMed
7) Kim SH, Nam EJ, Kim YK, et al. Functional variability of the adenosine A3 receptor (ADORA3) gene polymorphism in aspirin-induced urticaria. Br J Dermatol 2010 ; 163 : 977-85.
PubMed
8) Kim SH, Son JK, Yang EM, et al. A functional promoter polymorphism of the human IL18 gene is associated with aspirin-induced urticaria. Br J Dermatol 2011 ; 165 : 976-84.
PubMed
9) Sanchez-Borges M, Acevedo N, Vergara C, et al. The A-444C polymorphism in the leukotriene C4 synthase gene is associated with aspirin-induced urticaria. J Investig Allergol Clin Immunol 2009 ; 19 : 375-82.
 
10) Luong KV, Nguyen LT. Aquagenic urticaria : report of a case and review of the literature. Ann Allergy Asthma Immunol 1998 ; 80 : 483-5.
PubMed
11) Patterson R, Mellies CJ, Blankenship ML, et al. Vibratory angioedema : a hereditary type of physical hypersensitivity. J Allergy Clin Immun 1972 ; 50 : 174-82.
PubMed
12) Onn A, Levo Y, Kivity S. Familial cholinergic urticaria. J Allergy Clin Immunol 1996 ; 98 : 847-9.
PubMed
P.58 掲載の参考文献
1) Hashiro M. Psychosomatic treatment of a case of chronic urticaria. J Dermatol 1995 ; 22 : 686-9.
PubMed
2) Hashiro M, Yamatodani Y. A combination therapy of psychotropic drugs and antihistaminics or antiallergics in patients with chronic urticaria. J Dermatol Sci 1996 ; 11 : 209-13.
PubMed
3) Leonard BE. The immune system, depression and the action of antidepressants. Prog Neuropsychopharmacol Biol Psyichiatry 2001 ; 25 : 767-80.
PubMed
4) Mediratta PK, Sharma KK. Differential effects of benzodiazepines on immune responses in non-stressed and stressed animals. Indian J Med Sci 2002 ; 56 : 9-15.
PubMed
P.62 掲載の参考文献
1) 真鍋俊明, 幸田衛. 皮膚病理診断アトラス-組織像の見方と臨床像. 東京 : 文光堂 ; 1993. p6.
 
2) Ackerman AB, Chongchitnant N, Sanchez J, et al. Histologic Diagnosis of Inflammatory Skin Disease. 2nd ed. Baltimore : Williams & Wilkins ; 1997. p910.
 
3) Weedon D. Weedon's Skin Pathology. 3rd ed. London : Churchill Livingstone ; 2009. pp202-6.
 
4) Haas N, Toppe E, Henz BM. Microscopic morphology of different types of urticaria. Arch Dermatol 1998 ; 134 : 41-6.
PubMed
5) Sanchez JL, Benmaman O. Clinicopathological correlation in chronic urticaria. Am J Dermatopathol 1992 ; 14 : 220-3.
PubMed
6) Stewart GE 2nd. Histopathology of chronic urticaria. Clin Rev Allergy Immunol 2002 ; 23 : 195-200.
PubMed
7) Criado PR, Jardim Criado RF, Sotto MN, et al. Dermal dendrocytes FXIIIA+ phagocytizing extruded mast cell granules in drug-induced acute urticaria. J Eur Acad Dermatol Venereol 2013 ; 27 : e105-12.
PubMed
8) Vonakis BM, Saini SS. New concepts in chronic urticaria. Curr Opin Immunol 2008 ; 20 : 709-16.
PubMed
9) Nettis E, Dambra P, Loria MP, et al. Mast-cell phenotype in urticaria. Allergy 2001 ; 56 : 915.
PubMed
10) Smith CH, Kepley C, Schwartz LB, et al. Mast cell number and phenotype in chronic idiopathic urticaria. J Allergy Clin Immunol 1995 ; 96 : 360-4.
PubMed
11) Natbony SF, Phillips ME, Elias JM, et al. Histologic studies chronic idiopathic urticaria. J Allergy Clin Immunol 1983 ; 71 : 177-83.
PubMed
12) Kaplan AP, Greaves M. Pathogenesis of chronic urticaria. Clin Exp Allergy 2009 ; 39 : 777-87.
PubMed
13) Peters MS, Schroeter AL, Kephart GM, et al. Localization of eosinophil granule major basic protein in chronic urticaria. J Invest Dermatol 1983 ; 81 : 39-43.
PubMed
14) Peters MS, Winkelmann RK. Neutrophilic urticaria. Br J Dermatol 1985 ; 113 : 25-30.
PubMed
15) Llamas-Velasco M. Neutrophilic urticaria : descriptive study of 32 patients. J Am Acad Dermatol 2011 ; 64 (Suppl 1) : AB65.
 
16) Toppe E, Haas N, Henz BM, et al. Neutrophilic urticaria : clinical features, histological changes and possible mechanisms. Br J Dermatol 1998 ; 138 : 248-53.
PubMed
17) Tharp MD. Chronic urticaria : pathophysiology and treatment approaches. J Allergy Clin Immunol 1996 ; 98 : S325-30.
PubMed
18) Kieffer C, Cribier B, Lipsker D, et al. Neutrophilic urticarial dermatosis : a variant of neutrophilic urticaria strongly associated with systemic disease. Report of 9 new cases and review of the literature. Medicine (Baltimore) 2009 ; 88 : 23-31.
PubMed
19) Kobayashi H, Aiba S, Yamagishi T, et al. Cholinergic urticaria, a new pathogenic concept : hypohidrosis due to interference with the delivery of sweat to the skin surface. Dermatology 2002 ; 204 : 173-8.
 
20) Fukunaga A, Horikawa T, Sato M, et al. Aquired idiopathic generalized anhidrosis : possible pathogenic role of mast cells. Br J Dermatol 2009 ; 160 : 1337-40.
 
21) Chinuki Y, Tsumori T, Yamamoto O, et al. Cholinergic urticaria associated with acquired hypohidrosis : an ultrastructural study. Acta Derm Venereol 2011 ; 97 : 197-8.
 
22) Takahagi S, Tanaka T, Ishii K, et al. Sweat antigen induces histamine release from basophils of patients with cholinergic urticaria associated with atopic diathesis. Br J Dermatol 2009 ; 160 : 426-8.
PubMed
23) 澤田雄宇, 尾藤利憲, 戸倉新樹. 減汗性コリン性蕁麻疹の新知見. J Environ Dermatol Cutan Allergol 2011 ; 5 : 85-90.
Medical*Online
24) Soter NA, Austen KF, Gigli I. Urticaria, angioedema. Int J Dermatol 1979 ; 18 : 517.
 
25) Morioke S, Takahagi S, Iwamoto K, et al. Pressure challenge test and histopathological inspections for 17 Japanese cases with clinically diagnosed delayed pressure urticaria. Arch Dermatol Res 2010 ; 302 : 613-7.
PubMed
26) Mehregan DR, Hall MJ, Gibson LE. Urticarial vasculitis : a histopathologic and clinical review of 72 cases. J Am Acad Dermatol 1992 ; 26 : 441-8.
 
27) Peteiro C, Toribino J. Incidence of leukocytoclastic vasculitis in chronic idiopathic urticaria. Study of 100 cases. Am J Dermatopathol 1989 ; 11 : 528-33.
PubMed
28) Lee JS, Loh TH, Seow SC, et al. Prolonged urticaria with purpura : the spectrum of clinical and histopathologic features in a prospective series of 22 patients exhibiting the clinical features of urticarial vasculitis. J Am Acad Dermatol 2007 ; 56 : 994-1005.
 
P.71 掲載の参考文献
1) Sano A, Yagami A, Inaba Y, et al. Sensitization profiles of a case of pollen-food allergy syndrome. Allergol Int 2011 ; 60 : 97-101.
PubMed
2) Blanco C. Latex-fruit syndrome. Curr Allergy Asthma Rep 2003 ; 3 : 47-53.
PubMed
3) 松永佳世子. プリックテストのすすめ. 日皮会誌 2000 ; 63 : 54-8.
 
4) Yagami A, Suzuki K, Saito H, et al. Hev B 6.02 is the most important allergen in health care workers sensitized occupationally by natural rubber latex gloves. Allergol Int 2009 ; 58 : 347-55.
PubMed
5) Yagami A, Inaba Y, Kuno Y, et al. Two cases of pollen-food allergy syndrome to soy milk diagnosed by skin prick test, specific serum immunoglobulin E and microarray analysis. J Dermatol 2009 ; 36 : 50-5.
PubMed
6) Lachapelle J-M, Maibach HI. Patch Testing and Prick Testing : A Practical Guide. 2nd ed. Springer-Verlag : Berlin ; 2009. p144.
 
P.78 掲載の参考文献
1) 秀道広, 森田栄伸, 古川福実, ほか. 蕁麻疹診療ガイドライン. 日皮会誌 2011 ; 121 : 1339-88.
 
2) Asero R, Tedeschi A, Coppola R, et al. Activation of the tissue factor pathway of blood coagulation in patients with chronic urticaria. J Allergy Clin Immunol 2007 ; 119 : 705-10.
PubMed
3) 原田晋, 堀川達弥, 市橋正光, ほか. アスピリン蕁麻疹の多様性. 皮膚 1999 ; 41 : 312-8.
 
4) Siebenhaar F, Weller K, Mlynek A, et al. Aquired cold urticaria : clinical picture and update on diagnosis and treatment. Clin Exp Dermatol 2007 ; 32 : 241-5.
 
5) Horikawa T, Fukunaga A, Nishigori C. Solar urticaria. In : Zuberbier T, et al, editors. Urticaria and Angioedema. Heidelberg : Springer ; 2010. pp73-80.
 
6) Fukunaga A, Shimoura S, Fukunaga M, et al. Localized heat urticaria in a patient is associated with a wealing response to heated autologous serum. Br J Dermatol 2002 ; 147 : 994-7.
 
7) 佐々木絵里子, 山田陽三, 堀川達弥, ほか. Delayed pressure urticariaの1例. 日皮アレルギー会誌 2006 ; 14 : 139-42.
Medical*Online
8) Fukunaga A, Bito T, Tsuru K, et al. Responsiveness to autologous sweat and serum in cholinergic urticaria classifies its clinical subtypes. J Allergy Clin Immunol 2005 ; 116 : 397-402.
PubMed
P.83 掲載の参考文献
1) 三原祥嗣. 蕁麻疹における自己抗体の検査法とその読み方. 日皮会誌 2010 ; 120 : 2777-9.
 
2) 亀好良一. 原因のわからない蕁麻疹の原因は? 秀道広, ほか編. じんましん最前線. 東京 : メディカルレビュー社 ; 2007. pp38-42.
 
3) Niimi N, Francis DM, Kermani F, et al. Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria. J Invest Dermatol 1996 ; 106 : 1001-6.
PubMed
4) Sabroe RA, Seed PT, Francis DM, et al. Chronic idiopathic urticaria : comparison of the clinical features of patients with and without anti-FcεRI or anti-IgE autoantibodies. J Am Acad Dermatol 1999 ; 40 : 443-50.
 
5) Toubi E, Kessel A, Avshovich N, et al. Clinical and laboratory parameters in predicting chronic urticaria duration : a prospective study of 139 patients. Allergy 2004 ; 59 : 869-73.
PubMed
6) Grattan CE, O'Donnell BF, Francis DM, et al. Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria. Br J Dermatol 2000 ; 143 : 365-72.
PubMed
7) Di Gioacchino M, Di Stefano F, Cavallucci E, et al. Treatment of chronic idiopathic urticaria and positive autologous serum skin test with cyclosporine : clinical and immunological evaluation. Allergy Asthma Proc 2003 ; 24 : 285-90.
PubMed
8) Baskan EB, Tunali S, Turker T, et al. Comparison of short- and long-term cyclosporine A therapy in chronic idiopathic urticaria. J Dermatolog Treat 2004 ; 15 : 164-8.
 
9) Konstantinou GN, Asero R, Maurer M, et al. EAACI/GA2LEN task force consensus report : the autologous serum skin test in urticaria. Allergy 2009 ; 64 : 1256-68.
 
P.86 掲載の参考文献
1) 秀道広, 森田栄伸, 古川福実, ほか. 蕁麻疹診療ガイドライン. 日皮会誌 2011 ; 121 : 1339-88.
 
2) Cribier BJ, Santinelli F, Schmitt C, et al. Chronic urticaria is not significantly associated with hepatitis C or hepatitis G infection : a case-control study. Arch Dermatol 1999 ; 135 : 1335-9.
PubMed
3) Fukuda S, Shimoyama T, Umegaki N, et al. Effect of Helicobacter pylori eradication in the treatment of Japanese patients with chronic idiopathic urticaria. J Gastroenterol 2004 ; 39 : 827-30.
PubMed
4) Daschner A, De Frutos C, Valls A, et al. Anisakis simplex sensitization-associated urticaria : short-lived immediate type or prolonged acute urticaria. Arch Dermatol Res 2010 ; 302 : 625-9.
PubMed
5) O'Donnell BF, Francis DM, Swana GT, et al. Thyroid autoimmunity in chronic urticaria. Br J Dermatol 2005 ; 153 : 331-5.
PubMed
6) Verneuil L, Leconte C, Ballet JJ, et al. Association between chronic urticaria and thyroid autoimmunity : a prospective study involving 99 patients. Dermatology 2004 ; 208 : 98-103.
PubMed
7) Grattan CE, Humphreys F ; British Association of Dermatologists Therapy Guidelines and Audit Subcommittee. Guidelines for evaluation and management of urticaria in adults and children. Br J Dermatol 2007 ; 157 : 1116-23.
PubMed
P.89 掲載の参考文献
1) 秀道広, 森田栄伸, 古川福実, ほか. 蕁麻疹診療ガイドライン. 日皮会誌 2011 ; 121 : 1339-88.
 
1) 森田栄伸. 蕁麻疹と類症-抗ヒスタミン薬の使い分け. 皮膚病診療 2009 ; 31 : 101-5.
 
2) 森田栄伸. 蕁麻疹治療における抗ヒスタミン薬-患者の治療満足度と受療意識向上を目指した薬物治療. Progress in Medicine 2009 ; 29 : 1549-54.
Medical*Online
P.92 掲載の参考文献
1) 秀道広, 森田栄伸, 古川福実, ほか. 蕁麻疹診療ガイドライン. 日皮会誌 2011 ; 121 : 1339-88.
 
2) Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAAI/GA2LEN/EDF/WAO guideline : definition, classification and diagnosis of urticaria. Allergy 2009 ; 64 : 1417-26.
 
3) Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAAI/GA2LEN/EDF/WAO guideline : management of urticaria. Allergy 2009 ; 64 : 1427-43.
 
4) Mauer M, Altrichter S, Bieber T, et al. Efficacy and safety of omalizumab in patients with chronic uricaria who exhibit IgE against thyroperoxidase. J Allergy Clin Immunol 2011 ; 128 : 202-9.
 
5) Saini S, Rosen KE, Hsieh HJ, et al. A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria. J Allergy Clin Immunol 2011 ; 128 : 567-73.
PubMed
P.98 掲載の参考文献
1) Murota H, Katayama I. Assessment of antihistamines in the treatment of skin allergies. Curr Opin Allergy Clin Immunol 2011 ; 11 : 428-37.
PubMed
2) 秀道広, 森田栄伸, 古川福実, ほか. 蕁麻疹診療ガイドライン. 日皮会誌 2011 ; 121 : 1339-88.
 
3) Schulz S, Metz M, Siepmann D, et al. Antipruritic efficacy of a high-dosage antihistamine therapy : results of a retrospectively analyzed case series. Hautarzt 2009 ; 60 : 564-8.
 
4) Zuberbier T. Pharmacological rationale for the treatment of chronic urticaria with second-generation non-sedating antihistamines at higher-than-standard doses. J Eur Acad Dermatol Venereol 2012 ; 26 : 9-18.
PubMed
5) Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA2LEN/EDF/WAO guideline : management of urticaria. Allergy 2009 ; 64 : 1427-43.
 
6) Powell RJ, Du Toit GL, Siddique N, et al. BSACI guidelines for the management of chronic urticaria and angio-oedema. Clin Exp Allergy 2007 ; 37 : 631-50.
PubMed
7) Tedeschi A, Girolomoni G, Asero R ; AAITO Committee for Chronic Urticaria and Pruritus Guidelines. AAITO Position paper. Chronic urticaria : diagnostic workup and treatment. Eur Ann Allergy Clin Immunol 2007 ; 39 : 225-31.
PubMed
8) Joint Task Force on Practice Parameters. The diagnosis and management of urticaria : a practice parameter part I : acute urticaria/angioedema part II : chronic urticaria/angioedema. Joint Task Force on Practice Parameters. Ann Allergy Asthma Immunol 2000 ; 85 (6 Pt 2) : 521-44.
 
9) 森田栄伸. 皮膚疾患治療のポイント 抗ヒスタミン薬のPK/PD, 薬物構造をふまえた使い分け. 臨皮 2010 ; 64 : 100-4.
 
10) 谷内一彦, 田代学, 岡村信行. 中枢に移行しない第2世代抗ヒスタミン薬 : PETによる脳内移行性に関する研究. 西日皮膚 2009 ; 71 : 3-6.
 
11) Van Ruitenbeek P, Vermeeren A, Riedel WJ. Cognitive domains affected by histamine H (1) -antagonism in humans : a literature review. Brain Res Rev 2010 ; 64 : 263-82.
PubMed
12) Shamsi Z, Hindmarch I. Sedation and antihistamines : a review of inter-drug differences using proportional impairment ratios. Hum Psychopharmacol 2000 ; 15 : S3-30.
PubMed
P.102 掲載の参考文献
1) Boiko S, Zeiger R. Diagnosis and treatment of atopic dermatitis, urticaria, and angio-edema during pregnancy. Immunol Allergy Clin North Am 2000 ; 20 : 839-55.
 
2) 新石健二, 村田久仁男, 小西奈保美. 塩酸リトドリンによる薬疹との鑑別を要したPruritic Urticarial Papules and Plaques of Pregnancyの1例. 皮膚臨床 2011 ; 53 : 265-8.
 
3) 馬場俊右, 森康記, 渡部大輔, ほか. 接触皮膚炎との鑑別を要したpruritic urticarial papules and plaques of pregnancyの1例. 臨皮 2007 ; 61 : 125-7.
 
4) 長谷川佳子. PUPPP. MB Derma 2000 ; 36 : 23-7.
 
5) 向久保寿恵, 川上理子. pruritic urticarial papules and plaques of pregnancy (PUPPP). 皮膚病診療 2007 ; 29 : 927-30.
 
6) 森田栄伸. 抗ヒスタミン薬のPK/PD, 薬物構造をふまえた使い分け. 臨皮 2010 ; 64 (5 増) : 100-3.
 
7) 紫芝敬子. 妊娠性疱疹. Visual Dermatology 2006 ; 5 : 668-9.
 
8) 浦博伸, 紫芝敬子. 妊娠性痒疹. MB Derma 2000 ; 36 : 7-11.
 
9) 林昌洋. 内科医がとくに注意すべき相互作用・副作用-症状の捉え方と回避方法 : 妊娠. 内科 2001 ; 88 : 330-3.
 
10) Diav-Citrin O, Shechtman S, Aharonovich A, et al. Pregnancy outcome after gestational exposure to loratadine or antihistamines : a prospective controlled cohort study. J Allergy Clin Immunol 2003 ; 111 : 1239-43.
PubMed
11) Shaikh WA, Petitti D. Antihistamines and pregnancy. Ann Allergy Asthma Immunol 1997 ; 78 : 157-9.
 
P.105 掲載の参考文献
1) 谷岡未樹. インターネット調査で判明した蕁麻疹患者の意外な発想. 臨皮 2011 ; 65 : 143-5.
 
2) Stahle M, Hagermark O. Effects of topically applied clobetasol-17-propionate on histamine release in human skin. Acta Derm Venereol 1984 ; 64 : 239-42.
PubMed
3) Barlow RJ, Macdonald DM, Black AK. The effects of topical corticosteroids on delayed pressure urticaria. Arch Dermatol Res 1995 ; 287 : 285-8.
PubMed
4) Narasimha SK, Srinivas CR, Mathew AC. Effect of topical corticosteroid application frequency on histamine-induced wheals. Int J Dermatol 2005 ; 44 : 425-7.
PubMed
5) 秀道広, 森田栄伸, 古川福実, ほか. 蕁麻疹診療ガイドライン. 日皮会誌 2011 ; 121 : 1339-88.
 
P.108 掲載の参考文献
1) Aoki T, Kojima M, Horiko T. Acute urticaria : history and natural course of 50 cases. J Dermatol 1994 ; 21 : 73-7.
 
2) 幸野健. EBMから考える慢性蕁麻疹の患者説明と寛解時抗ヒスタミン薬中止方法-コンプライアンス向上を目指して. 皮膚アレルギーフロンティア 2007 ; 5 : 194-7.
Medical*Online
3) 秀道広. 慢性蕁麻疹はいつ治るのか. 宮地良樹, ほか編. EBM皮膚疾患の治療 2008-2009. 東京 : 中外医学社 ; 2008. pp48-52.
 
P.111 掲載の参考文献
1) 秀道広, 森田栄伸, 古川福実, ほか. 蕁麻疹診療ガイドライン. 日皮会誌 2011 ; 121 : 1339-88.
 
2) 北島康雄. 蕁麻疹と蕁麻疹様血管炎の膨疹の基本的な違い. Visual Dermatology 2010 ; 9 : 1294-7.
 
3) 小沢桂, 菊池智, 折笠玲子, ほか. c-kit遺伝子に点突然変異 (Asp816Val) を認めた肥満細胞症の3例. 日皮会誌 2005 ; 115 : 1023-8.
 
4) 調裕次, 日野奈保子, 藤本美穂, ほか. Schnitzler's syndromeの1例. 日皮会誌 2001 ; 111 : 945-53.
 
5) 藤澤章弘, 神戸直智, 齋藤潤, ほか. クライオピリン関連周期熱症候群 (cryopyrin-associated periodic syndrome) の1家系例. 日皮会誌 2007 ; 117 : 1445-50.
 
6) 小出純. 血清病. 綜合臨牀 1998 ; 47 : 527-30.
Medical*Online
7) 町田裕美子, 山本昌充, 土井久和. 蕁麻疹様紅斑で発症した急性B型肝炎. 皮膚病診療 2004 ; 26 : 1277-80.
 
8) 佐藤一也, 高後裕. Infusion reaction. 癌と化学療法 2008 ; 35 : 1671-4.
Medical*Online

II 血管性浮腫 ( 総論 )

P.118 掲載の参考文献
1) 池澤善郎. 血管性浮腫の診断と治療の進歩. 臨床免疫・アレルギー科 2011 ; 55 : 312-21.
 
2) 秀道広, 古江増隆, 池澤善郎, ほか. 蕁麻疹・血管性浮腫の治療ガイドライン. 日皮会誌 2005 ; 115 : 703-15.
 
3) 秀道広, 森田栄伸, 古川福実, ほか. 蕁麻疹診療ガイドライン. 日皮会誌 2011 ; 121 : 1339-88.
 
4) Bowen T, Cicardi M, Bork K, et al. Hereditary angiodema : a current state-of-theart review, VII : Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. Ann Allergy Asthma Immunol 2008 ; 100 (Suppl 2) : S30-40.
 
5) 補体研究会. 遺伝性血管性浮腫のガイドライン 2010. (http://square.umin.ac.jp/compl/HAE/HAEGuideline.html)
 
6) 高島明子, 桝谷法生, 横山安哉美, ほか. 妊娠継続が困難であった遺伝性血管神経性浮腫 (hereditary angioneurotic edema : HANE) 合併妊娠の1例. 日産婦関東連会報 2003 ; 40 : 437-40.
 
7) Yamamoto T, Horiuchi T, Miyahara H, et al. Hereditary angioedema in Japan : genetic analysis of 13 unrelated cases. Am J Med Sci 2012 ; 343 : 210-4.
PubMed
8) Iwamoto K, Tanaka A, Kawai M, et al. A large heterozygous deletion including the entire C1 inhibitor gene in a sporadic case of hereditary angio-oedema. Clin Exp Dermatol 2012 ; 37 : 20-3.
 
9) 岩本和真, 三原祥嗣, 池澤善郎, ほか. 遺伝性血管性浮腫の全国実態調査. アレルギー 2011 ; 60 : 26-32.
Medical*Online
10) Nzeako UC, Frigas E, Tremaine WJ. Hereditary angioedema : a broad review for clinicians. Arch Intern Med 2001 ; 161 : 2417-29.
PubMed
11) Nagashima M, Fujimura N, Matsuyama A, et al. Angioedema induced by angiotensin-converting enzyme inhibitor (ACE-I) ; report of a case and a review of cases reported in Japan. The 1st Eastern Asia Dermatology Congress, Hakata, 2010.
 
P.123 掲載の参考文献
1) Kaplan AP, Greaves MW. Angioedema. J Am Acad Dermatol 2005 ; 53 : 373-88.
PubMed
2) Vasekar M, Craig TJ. ACE inhibitor-induced angioedema. Curr Allergy Asthma Rep 2012 ; 12 : 72-8.
PubMed
3) Caballero T, Baeza ML, Cabanas R, et al. Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part I. Classification, epidemiology, pathophysiology, genetics, clinical symptoms, and diagnosis. J Investig Allergol Clin Immunol 2011 ; 21 : 333-47.
PubMed
4) 厚生労働省. 重篤副作用疾患別対応マニュアル. 血管性浮腫 (血管神経性浮腫). 2008. pp1-27.
 
5) Zuraw BL. Clinical practice. Hereditary angioedema. N Engl J Med 2008 ; 359 : 1027-36.
PubMed
6) Bork K, Wulff K, Hardt J, et al. Hereditary angioedema caused by missense mutations in the factor XII gene : clinical features, trigger factors, and therapy. J Allergy Clin Immunol 2009 ; 124 : 129-34.
PubMed
7) Bircher AJ. Drug-induced urticaria and angioedema caused by non-IgE mediated pathomechanisms. Eur J Dermatol 1999 ; 9 : 657-63.
PubMed
8) Hoover T, Lippmann M, Grouzmann E, et al. Angiotensin converting enzyme inhibitor induced angio-oedema : a review of the pathophysiology and risk factors. Clin Exp Allergy 2010 ; 40 : 50-61.
PubMed
9) Cugno M, Castelli R, Cicardi M. Angioedema due to acquired C1-inhibitor deficiency : a bridging condition between autoimmunity and lymphoproliferation. Autoimmun Rev 2008 ; 8 : 156-9.
PubMed
P.126 掲載の参考文献
1) 寺木祐一, 中村かおり, 三谷麗子, ほか. イトラコナゾールによる血管浮腫の1例. 皮膚臨床 2008 ; 50 : 796-7.
 
2) Zuraw BL. Clinical practice. Hereditary angioedema. N Engl J Med 2008 ; 359 : 1027-36.
PubMed
3) Parish LC. Hereditary angioedema : diagnosis and management-a perspective for the dermatologist. J Am Acad Dermatol 2011 ; 65 : 843-50.
PubMed
4) Bork K, Wulff K, Hardt J, et al. Hereditary angioedema caused by missense mutations in the factor XII gene : clinical features, trigger factors, and therapy. J Allergy Clin Immunol 2009 ; 124 : 129-34.
PubMed
P.129 掲載の参考文献
1) Grigoriadou S, Longhurst HJ. Clinical immunology review series : an approach to the patient with angio-oedema. Clin Exp Immunol 2009 ; 155 : 367-77.
 
2) Ciaccio CE. Angioedema : an overview and update. Mo Med 2011 ; 108 : 354-7.
PubMed
3) 池澤善郎. 血管性浮腫の診断と治療の進歩. 臨床免疫・アレルギー科 2011 ; 55 : 312-21.
 
4) Temino VM, Peebles RS Jr. The spectrum and treatment of angioedema. Am J Med 2008 ; 121 : 282-6.
PubMed
5) Frigas E, Park MA. Acute urticaria and angioedema : diagnostic and treatment considerations. Am J Clin Dermatol 2009 ; 10 : 239-50.
PubMed
6) 寺木祐一. 血管浮腫. 日本臨牀 2007 ; 65 : 353-6.
Medical*Online
7) 原田晋. NSAIDs過敏蕁麻疹/血管性浮腫. アレルギーの臨床 2007 ; 27 : 203-8.
 
8) 原田晋. 深部浮腫を伴う蕁麻疹への対応. MB Derma 2005 ; 105 : 66-73.
 
9) Charlesworth EN. Differential diagnosis of angioedema. Allergy Asthma Proc 2002 ; 23 : 337-9.
PubMed
10) Bracho FA. Hereditary angioedema. Curr Opin Hematol 2005 ; 12 : 493-8.
PubMed

III 蕁麻疹の病型 ( 各論 )

P.134 掲載の参考文献
1) 秀道広, 森田栄伸, 古川福実, ほか. 蕁麻疹診療ガイドライン. 日皮会誌 2011 ; 121 : 1339-88.
 
2) Aoki T, Kojima M, Horiko T. Acute urticaria : history and natural course of 50 patients. J Dermatol 1994 ; 21 : 73-7.
PubMed
3) Kauppinen K, Juntunen K, Lanki H. Urticaria in children. Retrospective evaluation and follow-up. Allergy 1984 ; 39 : 469-72.
PubMed
4) Zuberbier T, Ifflander J, Semmler C, et al. Acute urticaria-clinical aspects and therapeutical responsiveness. Acta Derm Venereol 1996 ; 76 : 295-7.
PubMed
5) Ricci G, Giannetti A, Belotti T, et al. Allergy is not the main trigger of urticaria in children referred to the emergency room. J Eur Acad Dermatol Venereol 2010 ; 24 : 1347-8.
PubMed
6) 宿輪哲生, 石川博士. 急性蕁麻疹における上気道炎の関与と血液学的異常所見. 国立病院機構長崎医療センター医学雑誌 2011 ; 13 : 26-8.
 
7) 塩原哲夫. 急性蕁麻疹への対応. MB Derma 2005 ; 105 : 29-34.
 
8) 奥野公成, 角田孝彦. 急性感染性蕁麻疹. 臨皮 2007 ; 61 : 34-6.
 
9) Sakurai M, Oba M, Matsumoto K, et al. Acute infectious urticaria : clinical and laboratory analysis in nineteen patients. J Dermatol 2000 ; 27 : 87-93.
PubMed
10) Asero R, Tedeschi A, Cugno M. Heparin and tranexamic acid therapy may be effective in treatment-resistant chronic urticaria with elevated d-dimer : a pilot study. Int Arch Allergy Immunol 2010 ; 152 : 384-9.
PubMed
11) Takahagi S, Mihara S, Iwamoto K, et al. Coagulation/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria. Allergy 2010 ; 65 : 649-56.
PubMed
12) 藤井公男, 小西研史, 菅野優子, ほか. IL-6はH1受容体阻害剤抵抗性の急性蕁麻疹の病態に関与する. 日皮アレルギー会誌 2003 ; 11 : 16-20.
Medical*Online
P.139 掲載の参考文献
1) 秀道広, 森田栄伸, 古川福実, ほか. 蕁麻疹診療ガイドライン. 日皮会誌 2011 ; 121 : 1339-88.
 
2) 柏浦正広. 蕁麻疹・アナフィラキシーの初期治療. レジデントノート 2010 ; 11 : 1448-52.
 
3) Sampson FE. Second symposium on the definition and management of anaphylaxis : summary report-second National Institute of Allergy and Infection Disease/Food Allergy and Anaphylaxis Network symposium. Ann Emerg Med 2006 ; 47 : 373-80.
 
P.145 掲載の参考文献
1) Bivings L. Acute infectious urticaria. J Pediatr 1946 ; 28 : 602-4.
PubMed
2) Federman DG, Kirsner RS, Moriarty JP, et al. The effect of antibiotic therapy for patients infected with Helicobacter pylori who have chronic urticaria. J Am Acad Dermatol 2003 ; 49 : 861-4.
PubMed
3) Powell RJ, Du Toit GL, Siiddique N, et al. BSACI guidelines for the management of chronic urticaria and angio-oedema. Clin Exp Allergy 2007 ; 37 : 631-50.
 
4) Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA2LEN/EDF/WAO guideline : definition, classification and diagnosis of urticaria. Allergy 2009 ; 64 : 1417-26.
 
5) 秀道広, 森田栄伸, 古川福実, ほか. 蕁麻疹診療ガイドライン. 日皮会誌 2011 ; 121 : 1339-88.
 
6) Kulthanan K, Chiawsirikajorn Y, Jiamton S. Acute urticaria : etiologies, clinical course and quality of life. Asian Pac J Allergy Immunol 2008 ; 26 : 1-9.
PubMed
7) Liu TH, Lin YR, Yang KC, et al. First attack of acute urticaria in pediatric emergency department. Pediatr Neonatol 2008 ; 49 : 58-64.
PubMed
8) Micheletti R, Rosenbach M. An approach to the hospitalized patient with urticaria and fever. Dermatol Ther 2011 ; 24 : 187-95.
 
9) 塩原哲夫. 急性蕁麻疹への対応. MB Derma 2005 ; 105 : 29-34.
 
10) Wedi B, Raap U, Wieczorek D, et al. Urticaria and infections. Allergy Asthma Clin Immunol 2009 ; 5 : 10
PubMed
11) 山下典子. 発熱を伴った急性蕁麻疹の臨床的組織学的研究. 東女医大誌 1990 ; 60 : 765-6.
 
12) 宮田義久, 鈴木民夫. 急性感染性蕁麻疹の10例. 臨皮 2002 ; 56 : 492-4.
 
13) 角田孝彦. いわゆる急性感染性蕁麻疹について. 日臨皮医会誌 1997 ; 52 : 95-9.
 
14) Ebell MH, Smith MA, Barry HC, et al. The rational clinical examination. Does this patient have strep throat? JAMA 2000 ; 284 : 2912-8.
PubMed
15) Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign : international guidelines for management of severe sepsis and septic shock : 2008. Crit Care Med 2008 ; 36 : 296-327.
PubMed
P.149 掲載の参考文献
1) 秀道広, 森田栄伸, 古川福実, ほか. 蕁麻疹診療ガイドライン. 日皮会誌 2011 ; 121 : 1339-88.
 
2) Kozel MM, Mekkes JR, Bossuyt PM, et al. The effectiveness of a history-based diagnostic approach in chronic urticaria and angioedema. Arch Dermatol 1998 ; 134 : 1575-80.
PubMed
3) Kozel MM, Bossuyt PM, Mekkes JR, et al. Laboratory tests and identified diagnoses in patients with physical and chronic urticaria and angioedema : a systematic review. J Am Acad Dermatol 2003 ; 48 : 409-16.
PubMed
4) Federman DG, Kirsner RS, Moriarty JP, et al. The effect of antibiotic therapy for patients infected with Helicobacter pylori who have chronic urticaria. J Am Acad Dermatol 2003 ; 49 : 861-4.
PubMed
5) Kowalski ML, Makowska JS, Blanca M, et al. Hypersensitivity to nonsteroidal antiinflammatory drugs (NSAIDs) -classification, diagnosis and management : review of the EAACI/ENDA (#) and GA2LEN/HANNA*. Allergy 2011 ; 66 : 818-29.
PubMed
6) Magerl M, Pisarevskaja D, Scheufele R, et al. Effects of a pseudoallergen-free diet on chronic spontaneous urticaria : a prospective trial. Allergy 2010 ; 65 : 78-83.
PubMed
7) Konstantinou GN, Asero R, Maurer M, et al. EAACI/GA2LEN task force consensus report : the autologous serum skin test in urticaria. Allergy 2009 ; 64 : 1256-68.
 
8) Dreskin SC, Andrews KY. The thyroid and urticaria. Curr Opin Allergy Clin Immunol 2005 ; 5 : 408-12.
PubMed
9) Lindelof B, Sigurgeirsson B, Wahlgren CF, et al. Chronic urticaria and cancer : an epidemiological study of 1155 patients. Br J Dermatol 1990 ; 123 : 453-6.
PubMed
10) Chen YJ, Wu CY, Shen JL, et al. Cancer risk in patients with chronic urticaria : a population-based cohort study. Arch Dermatol 2012 ; 148 : 103-8.
PubMed
P.155 掲載の参考文献
1) 秀道広, 森田栄伸, 古川福実, ほか. 蕁麻疹診療ガイドライン. 日皮会誌 2011 ; 121 : 1339-88.
 
2) Kubo N, Senda M, Ohsumi Y, et al. Brain histamine H1 receptor occupancy of loratadine measured by positron emission topography : comparison of H1 receptor occupancy and proportional impairment ratio. Hum Psychopharmacol 2011 ; 26 : 133-9.
PubMed
3) 森田栄伸. 蕁麻疹と類症 抗ヒスタミン薬の使い分け. 皮膚病診療 2009 ; 31 : 101-5.
 
4) 幸野健, 石田勲, 高橋祐史, ほか. 慢性蕁麻疹患者に対する抗ヒスタミン薬の系統変換法 (いわゆる森田療法) の評価. 日皮会誌 2011 ; 121 : 571.
 
5) Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA2LEN/EDF/WAO guideline : management of urticaria. Allergy 2009 ; 64 : 1427-43.
 
P.163 掲載の参考文献
1) Quaranta JH, Rohr AS, Rachelefsky GS, et al. The natural history and response to therapy of chronic urticaria and angioedema. Ann Allergy 1989 ; 62 : 421-4.
PubMed
2) Kennard CD. Evaluation and treatment of urticaria. Immunol Allergy Clin N Am 1995 ; 15 : 785-801.
 
3) Kozel MMA, Mekkes JR, Bossuyt PMM, et al. Natural course of physical and chronic urticaria and angioedema in 220 patients. J Am Acad Dermatol 2001 ; 45 : 387-91.
 
4) Van der Valk PGM, Moret G, Kiemeney LALM. The natural history of chronic urticaria and angioedema in patients visiting a tertiary referral centre. Br J Dermatol 2002 ; 146 : 110-3.
PubMed
5) Jiamton S, Kulthanan K, Swad-Ampiraks P, et al. Urticaria and angioedema in Siriraj medical students. J Med Assoc Thai 2003 ; 86 : 74-81.
PubMed
6) 片山一朗. 長崎大学皮膚科における蕁麻疹患者の予後とQOLに関するアンケート調査. 西日皮膚 2000 ; 62 : 89-94.
 
7) 石黒直子, 山田美奈, 川島眞. 慢性蕁麻疹の予後に関する臨床的検討. 皮膚臨床 2009 ; 51 : 885-9.
 
P.167 掲載の参考文献
1) 三原祥嗣. 蕁麻疹における自己抗体の検査法とその読み方. 日皮会誌 2010 ; 120 : 2777-9.
 
2) Cebeci F, Tanrikut A, Topcu E, et al. Association between chronic urticaria and thyroid autoimmunity. Eur J Dermatol 2006 ; 16 : 402-5.
PubMed
3) Mozena JD, Tinana A, Negri J, et al. Lack of a role for cross-reacting anti-thyroid antibodies in chronic idiopathic urticaria. J Invest Dermatol 2010 ; 130 : 1860-5.
PubMed
4) 秀道広, 森田栄伸, 古川福実, ほか. 蕁麻疹診療ガイドライン. 日皮会誌 2011 ; 121 : 1339-88.
 
5) Zuberbier T, Asero R, Bindslev-Jensen C, et al. Dermatology Section of the European Academy of Allergology and Clinical Immunology ; Global Allergy and Asthma European Network ; European Dermatology Forum ; World Allergy Organization. EAACI/GA2LEN/EDF/WAO guideline. Definition, classification and diagnosis of urticaria. Allergy 2009 ; 64 : 1417-26.
 
6) 亀好良一. 原因のわからない蕁麻疹の原因は? 秀道広, ほか編. じんましん最前線. 東京 : メディカルレビュー社 ; 2007. pp38-42.
 
7) Konstantinou GN, Asero R, Maurer M, et al. EAACI/GA2LEN task force consensus report : the autologous serum skin test in urticaria Allergy 2009 ; 64 : 1256-68.
 
8) Niimi N, Francis DM, Kermani F, et al. Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria. J Invest Dermatol 1996 ; 106 : 1001-6.
PubMed
9) Greaves MW, Kaplan AP, Grattan C. Diagnostic techniques for urticaria and angioedema. In : Kaplan AP, et al, editors. Urticaria and Angioedema. 2nd ed. New York : Informa Healthcare ; 2009. pp141-52.
 
10) Sabroe RA, Seed PT, Francis DM, et al. Chronic idiopathic urticaria : comparison of the clinical features of patients with and without anti-FcεRI or anti-IgE autoantibodies. J Am Acad Dermatol 1999 ; 40 : 443-50.
 
11) Toubi E, Kessel A, Avshovich N, et al. Clinical and laboratory parameters in predicting chronic urticaria duration : a prospective study of 139 patients. Allergy 2004 ; 59 : 869-73.
PubMed
12) Bagenstose SE, Levin L, Bernstein JA. The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results. J Allergy Clin Immunol 2004 ; 113 : 134-40.
PubMed
13) Grattan CE, O'Donnell BF, Francis DM, et al. Randomized double-blind study of cyclosporin in chronic' idiopathic' urticaria. Br J Dermatol 2000 ; 143 : 365-72.
PubMed
14) Di Gioacchino M, Di Stefano F, Cavallucci E, et al. Treatment of chronic idiopathic urticaria and positive autologous serum skin test with cyclosporine : clinical and immunological evaluation. Allergy Asthma Proc 2003 ; 24 : 285-90.
PubMed
15) Baskan EB, Tunali S, Turker T, et al. Comparison of short- and long-term cyclosporine A therapy in chronic idiopathic urticaria. J Dermatolog Treat 2004 ; 15 : 164-8.
 
P.172 掲載の参考文献
1) Amlot PL, Kemeny DM, Zachary C, et al. Oral allergy syndrome (OAS) : symptoms of IgE-mediated hypersensitivity to foods. Clin Allergy 1987 ; 17 : 33-42.
PubMed
2) Ortolani C, Ispano M, Pastorello E, et al. The oral allergy syndrome. Ann Allergy 1988 ; 61 : 47-52.
PubMed
3) Ma S, Sicerer SH, Nowak-Wagrzyn A. A survey on the management of pollenfood allergy syndrome in allergy practice. J Allergy Clin Immunol 2003 ; 112 : 784-8.
 
4) Aihara Y, Kotoyori T, Takahashi Y, et al. The necessity for dual food intake to provoke food dependent exercise-induced anaphylaxis (FEIAn) : a case report of FEIAn with simultaneous intake of wheat and umeboshi. J Allergy Clin Immunol 2001 ; 107 : 1100-5.
PubMed
5) Blanco C, Carrrillo T, Castillo R, et al. Latex allergy : clinical features and crossreactivity with fruits. Ann Allergy 1994 ; 73 : 309-14.
 
6) NIAID-Sponsored Expert Panel. Guidelines for the Diagnosis and Management of Food Allergy in the United States : report of the NIAID-Sponsored Expert Panel. J Allergy Clin Immmunol 2010 ; 126 (6 Suppl) : S1-58.
 
7) Working Group of the Resuscitation Council (UK). Emergency treatment of anaphylactic reactions. Guidelines for healthcare providers. London : Resuscitation Council (UK) ; 2008. (http://www.resus.org.uk/pages/reaction.pdf)
 
8) Sheikh A, Shehata YA, Brown SGA, et al. Adrenaline for the treatment of anaphylaxis : Cochrane systemic review. Allergy 2009 ; 124 : 625-36.
 
9) Sampson HA, Mendelson L, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med 1992 ; 327 : 380-4.
PubMed
10) Hansen KS, Khinchi MS, Skov PS, et al. Food allergy to apple and specific immunotherapy with birch pollen. Mol Nutr Food Res 2004 ; 48 : 441-8.
PubMed
11) Bucher X, Pichler WJ, Dahinden CA, et al. Effect of tree pollen specific, subcutaneous immunotherapy on the oral allergy syndrome to apple and hazelnut. Allergy 2004 ; 59 : 1272-6.
PubMed
12) Asero R. How long does the effect of birch pollen injection SIT on appler allergy last? Allergy 2003 ; 58 : 435-8.
 
13) Fisher HR, du Toit G, Lack G. Specific oral tolerance induction in food allergic children : is oral desensitisation more effective than allergen avoidance? : a meta-analysis of published RCTs. Arch Dis Child 2011 ; 96 : 259-64.
PubMed
14) Bindslev-Jansen C, Vibits A, Stahl Skov P, et al. Oral Allergy syndrome : effective of astemizol. Allergy 1991 ; 46 : 610-3.
 
15) Longo G, Baribi E, Berti I, et al. Specific oral tolerance induction in children with very severe cow's milk-induced reactions. J Alelrgy Clin Immunol 2008 ; 121 : 343-7.
 
16) Skripak JM, Nash SD, Rowley H, et al. A randomized double-blind, placebo-controlled study of milk allergy. J Allergy Clin Immunol 2008 ; 122 : 1154-60.
 
P.178 掲載の参考文献
1) Amlot PL, Kemeny DM, Zachary C, et al. Oral allergy syndrome (OAS) : symptoms of IgE-mediated hypersensitivity to foods. Clin Allergy 1987 ; 17 : 33-42.
PubMed
2) Ortolani C, Ispano M, Pastorello E, et al. The oral allergy syndrome. Ann Allergy 1988 ; 61 : 47-52.
PubMed
3) 猪又直子. 口腔アレルギー症候群. 食物アレルギー A to Z. 東京 : 第一出版 ; 2010. pp25-31.
 
4) Gajhede M, Osmark P, Poulsen FM, et al. X-ray and NMR structure of Bet v 1, the origin of birch pollen allergy. Nat Struct Biol 1996 ; 3 : 1040-5.
 
5) Mari A, Ballmer-Weber BK, Vieths S. The oral allergy syndrome : improved diagnostic and treatment methods. Curr Opin Allergy Clin Immunol 2005 ; 5 : 267-73.
PubMed
6) 猪又直子. 口腔アレルギー症候群. J Environ Dermatol Cutan Allergol 2010 ; 4 : 125-36.
Medical*Online
7) 猪又直子. 臨床現場からとらえた感作と発症 口腔アレルギー症候群における抗原感作と発症機序. アレルギー・免疫 2011 ; 19 : 56-68.
 
8) 河原秀俊, 赤澤晃. 小児科におけるOral allergy syndrome. アレルギー・免疫 2001 ; 8 : 882-5.
 
9) Hasegawa M, Inomata N, Yamazaki H, et al. Clinical features of four cases with cashew nut allergy and cross-reactivity between cashew nut and pistachio. Allergol Int 2009 ; 58 : 209-15.
PubMed
10) Yagami T. Allergies to cross-reactive plant proteins. Latex-fruit syndrome is comparable with pollen-food allergy syndrome. Int Arch Allergy Immunol 2002 ; 128 : 271-79.
PubMed
11) 猪又直子, 相原道子. 成人の食物アレルギーの特徴, 原因食物, 自然史. Visual Dermatology 2012 ; 11 : 272-9.
 
12) Inomata N, Morita A, Sawaki H, et al. Case of rice allergy induced by epicutaneous sensitization with rice bran due to the handling rice-bran pickles. J Dermatol 2012 ; 39 : 1079-80.
 
13) 守田亜希子, 猪又直子, 近藤恵, ほか. アナフィラキシーまでに至ったレタス, チコリによる職業性接触蕁麻疹症候群の1例. 日本皮膚アレルギー学会総会・日本接触皮膚炎学会総会合同学術大会プログラム. 抄録集36回・31回. 2006. p90.
 
14) 山口絢子, 猪又直子, 広門未知子, ほか. シーフードによる職業性の接触蕁麻疹と口腔アレルギー症候群の1例. アレルギー 2006 ; 56 : 49-53.
 
15) Sampson HA. Food allergy. J Allergy Clin Immunol 2004 ; 113 ; 805-19.
PubMed
16) 猪又直子, 池澤善郎. アレルギー性蕁麻疹の見方・捉え方. J Environ Dermatol Cutan Allergol 2006 ; 14 : 73-80.
 
17) 猪又直子. アレルゲンとしての食品 : 進化するアレルギー診断学 Component-resolved diagnostics. 日本小児アレルギー学会誌 2011 ; 25 : 36-49.
 
18) 守田亜希子, 猪又直子, 桐野実緒, ほか. 横浜近郊における, ハンノキ花粉感作と植物性食物による口腔アレルギー症候群の関連について. アレルギー 2008 ; 57 : 138-46.
Medical*Online
19) Maeda N, Inomata N, Morita A, et al. Correlation of oral allergy syndrome due to plant-derived foods with pollen sensitization in Japan. Ann Allergy Asthma Immunol 2010 ; 104 : 205-10.
PubMed
20) Dreborg S, Foucard T. Allergy to apple, carrot and potato in children with birch pollen allergy. Allergy 1983 ; 38 : 167-72.
PubMed
21) Lombardero M, Garcia-Selles FJ, Polo F, et al. Prevalence of sensitization to Artemisia allergens Art v 1, Art v 3 and Art v 60 kDa. Cross-reactivity among Art v 3 and other relevant lipid-transfer protein allergens. Clin Exp Allergy 2004 ; 34 : 1415-21.
PubMed
22) Kazemi-Shirazi L, Niederberger V, Linhart B, et al. Recombinant marker allergens : diagnostic gatekeepers for the treatment of allergy. Int Arch Allergy Immunol 2002 ; 127 : 259-68.
PubMed
23) Asero R. Effects of birch pollen-specific immunotherapy on apple allergy in birch pollen-hypersensitive patients. Clin Exp Allergy 1998 ; 28 : 1368-73.
PubMed
24) Kinaciyan T, Jahn-Schmid B, Radakovics A, et al. Successful sublingual immunotherapy with birch pollen has limited effects on concomitant food allergy to apple and the immune response to the Bet v 1 homolog Mal d 1. J Allergy Clin Immunol 2007 ; 119 : 937-43.
 
P.186 掲載の参考文献
1) Jones SM, Pons L, Roberts JL, et al. Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol 2009 ; 124 : 292-300.
PubMed
2) Nettis E, Colanardi MC, Soccio AL, et al. Double-blind, placebo-controlled study of sublingual immunotherapy in patients with latex-induced urticaria : a 12-month study. Br J Dermatol 2007 ; 156 : 674-81.
PubMed
3) Gastaminza G, Algorta J, Uriel O, et al. Randomized, double-blind, placebo-controlled clinical trial of sublingual immunotherapy in natural rubber latex allergic patients. Trials 2011 ; 12 : 191.
PubMed
4) 平田博国, 福田健. 免疫療法の実際 ハチ・アレルギー. アレルギーの臨床 2006 ; 26 : 201-6.
 
5) 栗原和幸. 食べて治す食物アレルギー. 東京 : 診断と治療社 ; 2010. pp56-89.
 
6) 西原冬実, 永田真. アレルゲン免疫療法が有効なアレルギーは何か? 小児内科 2006 ; 38 : 109-12.
 
7) Boyce JA, Assa'ad A, Burks AW, et al. Guidelines for the Diagnosis and Management of Food Allergy in the United States : Summary of the NIAID-Sponsored Expert Panel Report. J Allergy Clin Immunol 2010 ; 126 : 1105-18.
 
P.189 掲載の参考文献
1) Morita E, Kohno K, Matsuo H. Food-dependent exercise-induced anaphylaxis. J Dermatol Sci 2007 ; 47 : 109-17.
 
2) 望月満, 森本謙一, 秀道広. 食物依存性運動誘発アナフィラキシー. 小児科診療 2003 ; 43 (Suppl) : 39-43.
 
3) 草加一帆, 矢野博己, 加藤保子. アレルゲン胃内投与後の急性運動が感作マウスのアレルゲンの消化性とアナフィラキシー症状に及ぼす影響. 川崎医療福祉学会誌 2001 ; 11 : 331-9.
 
4) 松尾裕彰, 森田栄伸. 小麦依存性運動誘発アナフィラキシー. アレルギー科 2005 ; 19 : 326-31.
 
5) Matsuo H, Morimoto K, Akaki T, et al. Exercise and aspirin increase levels of circulating gliadin peptides in patients with wheat-dependent exercise-induced anaphylaxis. Clin Exp Allergy 2005 ; 35 : 461-6.
PubMed
6) Morita E, Matsuo H, Chinuki Y, et al. Food-dependent exercise-induced anaphylaxis -importance of omega-5 gliadin and HMW-glutenin as causative antigens for wheat-dependent exercise-induced anaphylaxis. Allergol Int 2009 ; 58 : 493-8.
PubMed
7) Harada S, Horikawa T, Ashida M, et al. Aspirin enhances the induction of type I allergic symptoms when combined with food and exercise in patients with fooddependent exercise-induced anaphylaxis. Br J Dermatol 2001 ; 145 : 336-9.
PubMed
8) Aihara M, Miyazawa M, Osuna H, et al. Food-dependent exercise-induced anaphylaxis : influence of concurrent aspirin administration on skin testing and provocation. Br J Dermatol 2002 ; 146 : 466-72.
PubMed
9) 井上友介, 足立厚子, 上野充彦, ほか. 小麦依存性運動誘発アナフィラキシー患者におけるアスピリン前投与誘発に対するプロスタグランジンE1製剤の抑制効果について. アレルギー 2009 ; 58 : 1418-25.
 
10) Takahashi A, Nakajima K, Ikeda M, et al. Pre-treatment with misoprostol prevents food-dependent exercise-induced anaphylaxis (FDEIA). Int J Dermatol 2011 ; 50 : 237-8.
PubMed
11) Matsuo H, Kohno K, Niihara H, et al. Specific IgE determination to epitope peptides of omega-5 gliadin and high molecular weight glutenin subunit is a useful tool for diagnosis of wheat-dependent exercise-induced anaphylaxis. J Immunol 2005 ; 175 : 8116-22.
PubMed
12) 千貫祐子, 松尾裕彰, 高橋仁, ほか. 小麦アレルギーの主要アレルゲンの同定. 臨床免疫・アレルギー科 2012 ; 58 : 63-71.
 
13) 千貫祐子, 森田栄伸. プリックテスト・スクラッチテスト・皮内反応の手技と評価. アレルギー・免疫 2010 ; 17 : 116-22.
 
14) Morita E. Food-dependent exercise-induced anaphylaxis. J Environ Dermatol 2006 ; 13 : 1-6.
 
15) 森田栄伸, 河野邦江, 松尾裕彰. 食物依存性運動誘発アナフィラキシーの運動負荷試験. 臨皮 2008 ; 62 : 64-7.
 
16) 泉佳菜子, 相原道子, 池澤善郎. 非ステロイド性消炎鎮痛薬 (NSAIDs) による即時型食物アレルギーの増強効果-わが国における最近10年の報告例の検討. アレルギー 2009 ; 58 : 1629-37.
 
17) 千貫祐子, 森田栄伸, 河野邦江, ほか. アスピリン負荷で誘発された小麦依存性運動誘発アナフィラキシー. Visual Dermatology 2009 ; 8 : 924-6.
 
18) 千貫祐子, 新原寛之, 河野邦江, ほか. 食物依存性運動誘発アナフィラキシー. Visual Dermatology 2007 ; 6 : 1136-7.
 
19) 千貫祐子, 崎枝薫, 金子栄, ほか. 石鹸中の加水分解小麦で感作され小麦依存性運動誘発アナフィラキシーを発症したと思われる3例. 日皮会誌 2010 ; 120 : 2421-5.
 
20) Chinuki Y, Kaneko S, Sakieda K, et al. A case of wheat-dependent exercise-induced anaphylaxis sensitized with hydrolysed wheat protein in a soap. Contact Dermatitis 2011 ; 65 : 55-7.
 
21) Chinuki Y, Kaneko S, Dekio S, et al. CD203c expression-based basophil activation test for diagnosis of wheat-dependent exercise-induced anaphylaxis. J Allergy Clin Immunol 2012 ; 129 : 1404-6.
 
22) Fukutomi Y, Itagaki Y, Taniguchi M, et al. Rhinoconjunctival sensitization to hydrolyzed wheat protein in facial soap can induce wheat-dependent exercise-induced anaphylaxis. J Allergy Clin Immunol 2011 ; 127 : 531-3.
PubMed
P.195 掲載の参考文献
1) Cohen SG, Zelaya-Quesada M. Portier, Richet, and the discovery of anaphylaxis : a centennial. J Allergy Clin Immunol 2002 ; 110 : 331-6.
PubMed
2) Sampson HA, Munoz-Furlong A, Bock SA, et al. Symposium on the definition and management of anaphylaxis : summary report. J Allergy Clin Immunol 2005 ; 115 : 584-91.
PubMed
3) Sampson HA, Munoz-Furlong A, Cambell RL, et al. Second symposium on the definition and management of anaphylaxis : summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006 ; 117 : 391-7.
 
4) Joint Task Force on Practice Parameters ; American Academy of Allergy, Asthma and Immunology ; American College of Allergy, Asthma and Immunology ; Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of anaphylaxis : an updated practice parameter. J Allergy Clin Immunol 2005 ; 115 : S483-523.
PubMed
5) Chiu AM, Kelly KJ. Anaphylaxis : drug allergy, insect stings, and latex. Immunol Allergy Clin North Am 2005 ; 25 : 389-405.
PubMed
6) 社団法人日本化学療法学会臨床試験委員会皮内反応検討特別部会. 抗菌薬投与に関するアナフィラキシー対策のガイドライン. 日本化学療法学会誌 2003 ; 51 : 497-506.
 
7) Oswalt ML, Kemp SF. Anaphylaxis : office management and prevention. Immunol Allergy Clin North Am 2007 ; 27 : 177-91.
PubMed
8) Sampson HA, Mendelson L, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med 1992 ; 327 : 380-48.
PubMed
9) 栗原和幸. 食べて治す食物アレルギー-特異的経口耐性誘導 (SOTI). 東京 : 診断と治療社 ; 2010.
 
10) 森田栄伸. アナフィラキシー (FDEIA, OASを含む). 皮膚臨床 2009 ; 51 : 1357-61.
 
11) Aihara M, Miyazawa M, Osuna H, et al. Food-dependent exercise-induced anaphylaxis : influence of concurrent aspirin administration on skin testing and provocation. J Dermatol 2002 ; 146 : 466-72.
 
12) Harada S, Horikawa T, Ashida M, et al. Aspirin enhances the induction of type I allergic symptoms when combined with food and exercise in patients with fooddependent exercise-induced anaphylaxis. Br J Dermatol 2001 ; 145 : 336-9.
PubMed
13) 古田淳二. 小麦による食餌性蕁麻疹. Visual Dermatology 2009 ; 8 : 913-5.
 
14) 上野充彦, 足立厚子, 下浦真一, ほか. クロモグリク酸ナトリウムで症状が抑制され, ミソプロストール (PGE1誘導体) で抑制されなかった小麦依存性運動誘発アナフィラキシーの1例. J Environ Dermatol Cutan Allergol 2008 ; 2 : 118-22.
 
15) Takahashi A, Nakajima K, Ikeda M, et al. Pre-treatment with misoprostol prevents food-dependent exercise-induced anaphylaxis (FDEIA). Int J Dermatol 2011 ; 50 : 237-8.
PubMed
16) Matsuo H, Morimoto K, Akaki T, et al. Exercise and aspirin increase levels of circulating gliadin peptides in patients with wheat-dependent exercise-induced anaphylaxis. Exp Allergy 2005 ; 35 : 461-6.
PubMed
P.199 掲載の参考文献
1) 桐ケ谷忠司, 櫻井有里子, 池野恵美. 魚中ヒスタミンによるアレルギー様食中毒に関する考察. 横浜衛研年報 1998 ; 37 : 99-102.
 
2) Juhlin L, Michaelsaan G, Zettrestom O. Urticaria and asthma induced by food-anddrug additives in patients with aspirin hypersensitivity. J Allergy Clin Immunol 1972 ; 50 : 92-8.
 
3) 竹中基, 片山一朗. アスピリン不耐症. MB Derma 2002 ; 64 : 52-7.
 
4) 原田晋. アスピリン不耐症. 玉置邦彦, ほか編. 最新皮膚科学大系 5. 薬疹・中毒疹. 東京 : 中山書店 ; 2003. pp187-193.
 
5) 松田三千雄, 昆みゆき, 森元洋介, ほか. 亜硫酸過敏症 : 悪性リンパ腫に合併した1例. 日皮会誌 1992 ; 102 : 497-503.
 
6) Kwok RHM. Chinese-restraunt syndrome (letter). N Engl J Med 1968 ; 278 : 796.
 
7) Williams AN, Woessner KM. Monosodium glutamate 'allergy' : menace or myth? Clin Exp Allergy 2009 ; 39 : 640-6.
PubMed
8) Zuberbier T, Chantraine S, Hartmann K, et al. Pseudoallergen-free diet in the treatment of chronic urticarial. a prospective study. Acta Derm Venereol 1995 ; 75 : 484-7.
 
9) Reese I, Zuberbier T, Bunselmeyer B, et al. Diagnostic approach for suspected pseudoallergic reaction to food ingredients. J Dtsch Dermatol Ges 2009 ; 1 : 70-7.
PubMed
10) Bunselmeyer B, Laubach HL, Schiller M, et al. Incremental build-up food challenge -a new diagnostic approach to evaluate pseudoallergic reactions in chronic urticarial : a pilot study. Clin Exp Allergy 2008 ; 39 : 116-26.
 
P.204 掲載の参考文献
1) 秀道広, 森田栄伸, 古川福実, ほか. 蕁麻疹診療ガイドライン. 日皮会誌 2011 ; 121 : 1339-88.
 
2) 猪又直子. アスピリン不耐症と蕁麻疹. 秀道広, ほか編. 皮膚科診療最前線シリーズ じんましん最前線. 東京 : メディカルレビュー社 ; 2007. pp70-3.
 
3) Stevenson DD, Sanchez-Borges M, Szczeklik A. Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann Allergy Asthma Immunol 2001 ; 87 : 177-80.
PubMed
4) Settipane RA, Constantine HP, Settipane GA. Aspirin intolerance and recurrent urticaria in normal adults and children. Epidemiology and review. Allergy 1980 ; 35 : 149-54.
PubMed
5) Stevenson DD, Simon RA. Sensitivity to aspirin and non-steroidal anti-inflammatory drugs. In : Middleton E, et al, editors. Allergy : Principles and Practice. 5th ed. St Louis : CV Mosby ; 1998. pp1225-34.
 
6) 猪又直子. 蕁麻疹の診断と治療. 日皮会誌 2008 ; 118 : 2383-95.
 
7) Asero R. Clinical management of adult patients with a history of nonsteroidal antiinflammatory drug-induced urticaria/angioedema : update. Allergy Asthma Clin Immunol 2007 ; 3 : 24-30.
PubMed
8) Inomata N, Osuna H, Yamaguchi J, et al. Safety of selective cyclooxygenase-2 inhibitors and a basic non-steroidal anti-inflammatory drug (NSAID) in Japanese patients with NSAID-induced urticaria and/or angioedema : comparison of meloxicam, etodolac and tiaramide. J Dermatol 2007 ; 34 : 172-7.
PubMed
9) Kong JS, Teuber SS, Gershwin ME. Aspirin and nonsteroidal anti-inflammatory drug hypersensitivity. Clin Rev Allergy Immunol 2007 ; 32 : 97-110.
PubMed
10) Kaplan AP, Greaves MW. Angioedema. J Am Acad Dermatol 2005 ; 53 : 373-88.
PubMed
11) Chandrasekharan NV, Dai H, Roos KL, et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs : cloning, structure, and expression. Proc Natl Acad Sci U S A 2002 ; 99 : 13926-31.
PubMed
12) Kis B, Snipes JA, Busija DW. Acetaminophen and the cyclooxygenase-3 puzzle : sorting out facts, fictions, and uncertainties. J Pharmacol Exp Ther 2005 ; 315 : 1-7.
PubMed
13) Tan EKH, Grattan CE. Drug-induced urticarial. Expert Opin Drug Saf 2004 ; 3 : 471-84.
PubMed
14) Kim SH, Ye YM, Lee SK, et al. Genetic mechanism of aspirin-induced urticaria/angioedema. Curr Opin Allergy Clin Immunol 2006 ; 6 : 266-70.
PubMed
15) Harada S, Horikawa T, Ashida M, et al. Aspirin enhances the induction of type I allergic symptoms when combined with food and exercise in patients with fooddependent exercise-induced anaphylaxis. Br J Dermatol 2001 ; 145 : 336-9.
PubMed
16) Inomata N. Wheat allergy. Curr Opin Allergy Clin Immunol 2009 ; 9 : 238-43.
PubMed
17) Pacor ML, Di Lorenzo G, Corrocher R. Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acid. Clin Exp Allergy 2001 ; 31 : 1607-14.
PubMed
18) Grzelewska-Rzymowska I, Roznlecki J, Szmidt M. Aspirin "desensitization" in patients with aspirin-induced urticaria and angioedema. Allergol Immunopathol 1988 ; 16 : 305-8.
PubMed
19) Simon RA. Prevention and treatment of reactions to NSAIDs. Clin Rev Allergy Immunol 2003 ; 24 : 189-98.
PubMed
P.211 掲載の参考文献
1) 福田英三. 薬疹情報. 第14版. 福岡 : 医療法人福田皮ふ科 ; 2011. pp466-78.
 
2) 秋山正基, 飯島正文. イオヘキソールによる薬疹の3例. 皮膚 1990 ; 32 (Suppl 8) : 210-4.
 
3) 秋山正基, 飯島正文, 藤澤龍一. Iohexol (Omnipaque(R)) による薬疹の臨床的検討. 日皮会誌 1990 ; 100 : 1057-60.
 
4) 秋山正基, 飯島正文. 古くて新しい薬疹 : 非イオン性ヨード造影剤による薬疹. MB Derma 2004 ; 86 : 59-64.
 
5) 池澤善郎. 原因薬からみた薬疹の特徴. MB Derma 1998 ; 10 : 41-62.
 
6) 秋山正基, 永田茂樹, 飯島正文, ほか. 非イオン性ヨード造影剤イオヘキソールによる皮膚障害の統計的観察. 日皮アレルギー 1994 ; 1 : 324-7.
Medical*Online
P.214 掲載の参考文献
1) Swanbeck G, Dahlberg E. Cutaneous drug reactions. An attempt to quantitative estimation. Arch Dermatol Res 1992 ; 284 : 215-18.
PubMed
2) 秀道広, 森田栄伸, 古川福実, ほか. 蕁麻疹診療ガイドライン. 日皮会誌 2011 ; 121 : 1339-88.
 
3) 松尾明子, 稲沖真, 藤本亘. 塩酸セフォチアム (パンスポリン) による接触蕁麻疹症候群. 皮膚病診療 2004 ; 26 : 869-72.
 
4) 猪俣直子. 蕁麻疹の診断と治療. 日皮会誌 2008 ; 118 : 2383-95.
 
5) Saxon A, Adelman DC, Patel A, et al. Imipenem cross-resactivity with penicillin in humans. J Allergy Clin Immunol 1988 ; 82 : 213-7.
 
6) 齋藤厚, 砂川慶介, 民山嘉伸, ほか. 社団法人日本化学療法学会臨床試験委員会皮内反応検討特別部会報告書. 日化療会誌 2003 ; 51 : 497-506.
 
7) 厚生労働省医薬食品局. 医薬品・医療用具等安全性情報 206号. http://www.mhlw.go.jp/houdou/2004/10/h1028-2a.html
 
P.219 掲載の参考文献
1) 田中稔彦, 亀好良一, 秀道広. 広島大学皮膚科外来での蕁麻疹の病型別患者数. アレルギー 2006 ; 55 : 134-9.
 
2) Kruger-Krasagakes S, Henz BM. Delayed pressure urticaria. In : Henz BM, et al, editors. Urticaria. Berlin : Springer-Verlag ; 1998. pp64-8.
 
3) Black AK. Physical and cholinergic urticarias. In : Kaplan AP, et al, editors. Urticaria and Angioedema. 2nd ed. New York : Informa Healthcare ; 2008. pp181-216.
 
4) Koro O, Dover JS, Francis DM, et al. Release of prostaglandin D2 and histamine in a case of localized heat urticaria. Br J Dermatol 1986 ; 115 : 721-8.
 
5) 森田栄伸. 温熱蕁麻疹. 玉置邦彦, ほか編. 最新皮膚科学大系 3 湿疹 痒疹 掻痒症 紅皮症 蕁麻疹. 東京 : 中山書店 ; 2002. pp223-4.
 
6) 後藤典子, 小倉香奈子, 賀茂統良, ほか. アスピリン内服が有効であった局所性温熱蕁麻疹の1例. J Environ Dermatol Cutan Allergol 2010 ; 4 : 214-9.
 
7) 森田栄伸. 蕁麻疹, 血管性浮腫. 古川福実, 編. 皮膚科典型アトラス 560. 東京 : 日本医事新報社 ; 2008. pp33-8.
 
8) Soter NA, Wasserman SI, Austen KF. Release into the circulation of histamine and eosinophil chemotactic factor of anaphylaxis during cold challenge. N Engl J Med 1976 ; 294 : 687-90.
PubMed
9) 小林桂子, 榊原代幸, 森田明理. 日光蕁麻疹. 皮膚病診療 2009 ; 31 : 29-32.
 
10) 森桶聡, 高萩俊輔, 亀好良一, ほか. 遅延性圧蕁麻疹. 皮膚病診療 2009 ; 25-8.
 
P.223 掲載の参考文献
1) Henz BM. Physical urticaria. In : Henz BM, et al, editors. Urticaria. Berlin : Springer-Verlag ; 1998, pp55-89.
 
2) Greaves MW, Sondegaad J. Urticaria pigmentosa and factitious urticaria : direct evidence for release of histamine and other smooth-muscle-contracting agents in dermographic skin. Arch Dermatol 1970 ; 101 : 418-25.
 
3) 大野健太郎, 堀川達弥, 錦織千佳子. シイタケ皮膚炎. Visual Dermatology 2009 ; 8 : 956-7.
 
4) 森田栄伸, 松尾裕彰, 出来尾哲. 人工蕁麻疹に対するオロパタジン (アレロック(R)) の臨床効果. 西日皮膚 2003 ; 65 : 172-4.
 
5) Sharpe GR, Shuster S. The effect of cetirizine on symptoms and wealing in dermographic urticaria. Br J Dermatol 1993 ; 129 : 580-3.
PubMed
6) Cap JP, Schwanitz HJ, Czarnetzki BM. Effect of ketotifen in urtaicaria factitia and urticaria cholinergica in a crossover double-blind trial. Hautarzt 1985 ; 36 : 509-11.
 
7) Borzova E, Rutherford A, Konstantinou GN, et al. Narrowband ultraviolet B phototherapy is beneficial in antihistamine-resistant symptomatic dermographism : a pilot study. J Am Acad Dermatol 2008 ; 59 : 752-7.
PubMed
8) 秀道広, 森田栄伸, 古川福実, ほか. 蕁麻疹診療ガイドライン. 日皮会誌 2011 ; 121 : 1339-88.
 
9) Cook J, Shuster S. The effect of H1 and H2 receptor antagonists on the dermographic response. Acta Derm Venereol 1983 ; 63 : 260-2.
PubMed
10) Kaur S, Greaves M, Eftekhari N. Factitious urticaria (dermographism) : treatment by cimetidine and chlorpheniramine in a randomized double-blind study. Br J Dermatol 1981 ; 104 : 185-90.
 
P.226 掲載の参考文献
1) 三原祥嗣, 秀道広. 全身性寒冷蕁麻疹. Visual Dermatology 2005 ; 4 : 690-1.
 
2) Siebenhaar F, Weller K, Mlynek A, et al. Acquired cold urticaria : clinical picture and update on diagnosis and treatment. Clin Exp Dermatol 2007 ; 32 : 241-5.
PubMed
3) Marsland AM, Beck MH. Cold urticaria responding to systemic ciclosporin. Br J Dermatol 2003 ; 149 : 214-5.
PubMed
4) 川上民裕. 日常診療に役立つ皮膚科最新情報 患者さんへの説明を含めて, 血管炎. 皮膚臨床 2009 ; 51 : 1462-73.
 
5) Boyce JA. Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE. J Allergy Clin Immunol 2006 ; 117 : 1415-8.
PubMed
6) Kawakami T. A review of pediatric vasculitis with a focus on juvenile polyarteritis nodosa. Am J Clin Dermatol 2012 ; 13 : 389-98.
PubMed
P.231 掲載の参考文献
1) Leenutaphong V, Holzle E, Plewig G. Pathogenesis and classification of solar urticaria : a new concept. J Am Acad Dermatol 1989 ; 21 : 237-40.
PubMed
2) Ryckaert S, Roelandts R. Solar urticaria. A report of 25 cases and difficulties in phototesting. Arch Dermatol 1998 ; 134 : 71-4.
PubMed
3) Monfrecola G, Masturzo E, Riccardo AM, et al. Solar urticaria : a report on 57 cases. Am J Contact Dermat 2000 ; 11 : 89-94.
PubMed
4) Uetsu N, Miyauchi-Hashimoto H, Okamoto H, et al. The clinical and photobiological characteristics of solar urticaria in 40 patients. Br J Dermatol 2000 ; 142 : 32-8.
PubMed
5) Beattie PE, Dawe RS, Ibbotson SH, et al. Characteristics and prognosis of idiopathic solar urticaria : a cohort of 87 cases. Arch Dermatol 2003 ; 139 : 1149-54.
PubMed
6) Palma-Carlos AG, Palma-Carlos ML. Solar urticaria and porphyrias. Eur Ann Allergy Clin Immunol 2005 ; 37 : 17-20.
PubMed
7) Miyauchi H, Horio T. Detection of action, inhibition and augmentation spectra in solar urticaria. Dermatology 1995 ; 191 : 286-91.
PubMed
8) Edstrom DW, Ros AM. Cyclosporin A therapy for severe solar urticaria. Photodermatol Photoimmunol Photomed 1997 ; 13 : 61-3.
PubMed
9) Botto NC, Warshaw EM. Solar urticaria. J Am Acad Dermatol 2008 ; 59 : 909-20 ; quiz 921-2.
 
P.237 掲載の参考文献
1) Duke WW. Urticaria caused specifically by the action of physical agent. J Am Med Ass 1924 ; 83 : 3-8.
 
2) 西野圭輔. Locarized heat urticariaの1例. 日皮会誌 1989 ; 99 : 757.
 
3) 久野由恵, 渡部裕子, 渡辺久代, ほか. H1-blockerおよびH2-blockerの併用療法が奏功した局所性温熱蕁麻疹の1例. 臨皮 1993 ; 47 : 1199-202.
 
4) Baba T, Nomura K, Hanada K, et al. Immediate-type heat urticaria : report of a case and study of plasma histamine release. Br J Dermatol 1998 ; 138 : 326-8.
PubMed
5) Skrebova N, Takiwaki H, Miyaoka Y, et al. Localized heat urticaria. J Dermatol Sci 2001 ; 26 : 112-8.
PubMed
6) Fukunaga A, Shimoura A, Fukunaga M, et al. Localized heat urticaria in a patient is associated with a wealing response to heated autologous serum. Br J Dermatol 2002 ; 147 : 994-7.
 
7) 藤原進, 佐々木絵里子, 堀川達弥, ほか. 局所性温熱蕁麻疹の1例. 日皮アレルギー 2006 ; 14 : 39-42.
Medical*Online
8) 後藤典子, 小倉香奈子, 加茂統良, ほか. アスピリン内服が有効であった温熱蕁麻疹の1例. J Environ Dermatol Cutan Allergol 2010 ; 4 : 214-9.
 
9) 原田研, 竹本啓伸, 北村英夫, ほか. 温泉で意識消失を生じた即時型温熱蕁麻疹の症例. 皮膚臨床 2008 ; 50 : 794-5.
 
10) 小猿恒志, 足立厚子, 西岡美南, ほか. 局所性温熱蕁麻疹の1例. J Environ Dermatol Cutan Allergol 2011 ; 55 : 450-3.
 
11) Chang A, Zic JA. Localized heat urticaria. J Am Acad Dermatol 1999 ; 41 : 354-6.
PubMed
12) Bullerkotte U, Wieczorek D, Kapp A, et al. Effective treatment of refractory severe heat urticaria with omalizumab. Allergy 2010 ; 65 : 931-2.
PubMed
13) Koro O, Dover JS, Francis DM, et al. Release of prostandin D2 and histamine in a case of localized heat urticaria and effect of tratment. Br J Dermatol 1986 ; 115 : 721-8.
 
P.240 掲載の参考文献
1) 秀道広, 森田栄伸, 古川福実, ほか. 蕁麻疹診療ガイドライン. 日皮会誌 2011 ; 121 : 1339-88.
 
1) McEvoy MT, Peterson EA, Black AK, et al. Immunohistological comparison of granulated cell proteins in induced immediate urticarial dermographism and delayed pressure urticaria lesions. Br J Dermatol 1995 ; 133 : 853-60.
 
2) Barlow RJ, Warburton F, Watson K, et al. Diagnosis and incidence of delayed pressure urticaria in patients with chronic urticaria. J Am Acad Dermatol 1993 ; 29 : 954-8.
PubMed
3) Morioke S, Takahagi S, Iwamoto K, et al. Pressure challenge test and histopathological inspections for 17 Japanese cases with clinically diagnosed delayed pressure urticaria. Arch Dermatol Res 2010 ; 302 : 613-7.
PubMed
4) Black AK, Lawlor F, Greaves MW. Consensus meeting on the definition of physical urticarias and urticarial vasculitis. Clin Exp Dermatol 1996 ; 21 : 424-6.
PubMed
P.243 掲載の参考文献
1) Shelley WB, Rawnsley HM. Aquagenic urticaria. Contact sensitivity reaction to water. JAMA 1964 ; 189 : 895-8.
PubMed
2) Treudler R, Tabbe B, Steinhoff M, et al. Familial aquagenic urticaria associated with familial lactose intolerance. J Am Acad Dermatol 2002 ; 47 : 611-3.
 
3) Pitarch G, Torrijos A, Martinez-Menchon T, et al. Familial aquagenic urticaria and Bernard-Soulier syndrome. Dermatology 2006 ; 212 : 96-7.
PubMed
4) Gallo R, Cacciapuoti M, Cozzani E, et al. Localized aquagenic urticaria dependent on saline concentration. Contact Dermatitis 2001 ; 44 : 110-1.
PubMed
5) Gimenez-Arnau A, Serra-Baldrich E, Camarasa JG. Chronic aquagenic urticaria. Acta Derm Venereol (Stockh) 1992 ; 72 : 389.
 
6) Sibbald RG, Black AK, Eady RA, et al. Aquagenic urticaria : evidence of cholinergic and histaminergic basis. Br J Dermatol 1981 ; 105 : 297-302.
PubMed
7) Czarnetzki BM, Breetholt KH, Traupe H. Evidence that water acts as a carrier for an epidermal antigen in aquagenic urticaria. J Am Acad Dermatol 1986 ; 15 : 623-7.
PubMed
8) 真田聖子, 山村有美, 秀道広, ほか. 水性蕁麻疹の1例. 皮膚臨床 2000 ; 42 : 1023-6.
 
9) Luong KV, Nguyen LT. Aquagenic urticaria : report of a case and review of the literature. Ann Allergy Asthma Immunol 1998 ; 80 : 483-5.
PubMed
10) Martinez-Escribano JA, Quecedo E, De la Cuadra J, et al. Treatment of aquagenic urticaria with PUVA and astemizole. J Am Acad Dermatol 1997 ; 36 : 118-9.
PubMed
11) Baptist AP, Baldwin JL. Aquagenic urticaria with extracutaneous manifestations. Allergy Asthma Proc 2005 ; 26 : 217-20.
PubMed
P.246 掲載の参考文献
1) Patterson R, Mellies CJ, Blankenship ML, et al. Vibratory angioedema : a hereditary type of physical hypersensitivity. J Allergy Clin Immunol 1972 ; 50 : 174-82.
PubMed
2) Lawlor F, Black AK, Breathnach AS, et al. Vibratory angioedema : lesion induction, clinical features, laboratory and ultrastructural findings and response to therapy. Br J Dermatol 1989 ; 120 : 93-9.
PubMed
3) Rose MH. Vibratory urticaria associated with bladder-wall infection with the yeast Torulopsis glabrata. J Allergy Clin Immunol 1989 ; 84 : 408.
PubMed
4) Metzger WJ, Kaplan AP, Beaven MA, et al. Hereditary vibratory angioedema : confirmation of histamine release in a type of physical hypersensitivity. J Allergy Clin Immunol 1976 ; 57 : 605-8.
 
5) Mathelier-Fusade P, Vermeulen C, Leynadier F. Vibratory angioedema. Ann Dermatol Venereol 2001 ; 128 : 750-2.
PubMed
6) Keahey TM, Indrisano J, Lavker RM, et al. Delayed vibratory angioedema : insights into pathophysiologic mechanisms. J Allergy Clin Immunol 1987 ; 80 : 831-8.
PubMed
7) Patruno C, Ayala F, Cimmino G, et al. Vibratory angioedema in a saxophonist. Dermatitis 2009 ; 20 : 346-7.
 
8) Ting S, Reimann BE, Rauls DO, et al. Nonfamilial, vibration-induced angioedema. J Allergy Clin Immunol 1983 ; 71 : 546-51.
PubMed
9) Wener MH, Metzger WJ, Simon RA. Occupationally acquired vibratory angioedema with secondary carpal tunnel syndrome. Ann Intern Med 1983 ; 98 : 44-6.
PubMed
P.250 掲載の参考文献
1) Champion RH, Roberts SOB, Carpenter RG, et al. Urticaria and angioedema : a review of 554 patients. Br J Dermatol 1969 ; 81 : 588-97.
 
2) Zuberbier T, Althaus C, Chantraine-Hess S, et al. Prevalence of cholinergic urticaria in young adults. J Am Acad Dermatol 1994 ; 31 : 978-81.
PubMed
3) Nakamizo S, Egawa G, Miyachi Y, et al. Cholinergic urticaria : pathogenesis-based categorization and its treatment options. J Eur Acad Dermatol Venereol 2012 ; 26 : 114-6.
PubMed
4) Sawada Y, Nakamura M, Bito T, et al. Cholinergic urticaria : studies on the muscarinic cholinergic receptor M3 in anhidrotic and hypohidrotic skin. J Invest Dermatol 2010 ; 130 : 2683-6.
PubMed
5) Horikawa T, Fukunaga A, Nishigori C. New concepts of hive formation in cholinergic urticaria. Curr Allergy Asthma Rep 2009 ; 9 : 273-9.
PubMed
6) Sabroe RA. Cholinergic urticaria and exercise-induced anaphylaxis. In : Zuberbier T, et al, editors. Urticaria and Angioedema. 1st ed. Heidelberg : Springer ; 2010. pp81-9.
 
7) Kaplan AP, Garofalo J. Identification of a new physically induced urticaria : coldinduced cholinergic urticaria. J Allergy Clin Immunol 1981 ; 68 : 438-41.
PubMed
8) Takahagi S, Tanaka T, Ishii K, et al. Sweat antigen induces histamine release from basophils of patients with cholinergic urticaria associated with atopic diathesis. Br J Dermatol 2009 ; 160 : 426-8.
PubMed
9) Davis RS, Remigio LK, Schocket AL, et al. Evaluation of a patient with both aquagenic and cholinergic urticaria. J Allergy Clin Immunol 1981 ; 68 : 479-83.
PubMed
10) Mihara S, Hide M. Adrenergic urticaria in a patient with cholinergic urticaria. Br J Dermatol 2008 ; 158 : 629-31.
 
11) Fukunaga A, Horikawa T, Sato M, et al. Acquired idiopathic generalized anhidrosis : possible pathogenic role of mast cells. Br J Dermatol 2009 ; 160 : 1337-40.
PubMed
12) Fukunaga A, Bito T, Tsuru K, et al. Responsiveness to autologous sweat and serum in cholinergic urticaria classifies its clinical subtypes. J Allergy Clin Immunol 2005 ; 116 : 397-402.
PubMed
P.254 掲載の参考文献
1) Kaplan AP, Beaven MA. In vivo studies of the pathogenesis of cold urticaria, cholinergic urticaria, and vibration-induced swelling. J Invest Dermatol 1976 ; 67 : 327-32.
PubMed
2) Soter NA, Wasserman SI, Austen KF, et al. Release of mast-cell mediators and alterations in lung function in patients with cholinergic urticaria. N Engl J Med 1980 ; 302 : 604-8.
PubMed
3) Commens CA, Greaves MW. Tests to establish the diagnosis in cholinergic urticaria. Br J Dermatol 1978 ; 98 : 47-51.
PubMed
4) Fukunaga A, Bito T, Tsuru K, et al. Responsiveness to autologous sweat and serum in cholinergic urticaria classifies its clinical subtypes. J Allergy Clin Immunol 2005 ; 116 : 397-402.
PubMed
5) Sawada Y, Nakamura M, Bito T, et al. Cholinergic urticaria : studies on the muscarinic cholinergic receptor M3 in anhidrotic and hypohidrotic skin. J Invest Dermatol 2010 ; 130 : 2683-6.
PubMed
6) Adachi J, Aoki T, Yamatodani A. Demonstration of sweat allergy in cholinergic urticaria. J Dermatol Sci 1994 ; 7 : 142-9.
PubMed
7) Takahagi S, Tanaka T, Ishii K, et al. Sweat antigen induces histamine release from basophils of patients with cholinergic urticaria associated with atopic diathesis. Br J Dermatol 2009 ; 160 : 426-8.
PubMed
8) Horikawa T, Fukunaga A, Nisigori C. New concepts of hive formation in cholinergic urticaria. Curr Allergy Asthma Rep 2009 ; 9 : 273-9.
 
9) Zuberbier T, Althaus C, Chantraine-Hess S, et al. Prevalence of cholinergic urticaria in young adults. J Am Acad Dermatol 1994 ; 31 : 978-81.
PubMed
10) Metz M, Bergmann P, Zuberbier T, et al. Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy. Allergy 2008 ; 63 : 247-9.
PubMed
11) Sabroe RA. Failure of omalizumab in cholinergic urticaria. Clin Exp Dermatol 2010 ; 35 : e127-9.
PubMed
12) Kozaru T, Fukunaga A, Taguchi K, et al. Rapid desensitization with autologous sweat in cholinergic urticaria. Allergol Int 2011 ; 60 : 277-81.
PubMed
P.257 掲載の参考文献
1) Maibach HI, Johnson HL. Contact urticaria syndrome : contact urticaria to diethyl toluamide (immediate type hypersensitivity). Arch Dermatol 1975 ; 111 : 726-30.
PubMed
1) Gimenez-Arnau A, Maurer M, De La Cuadra J, et al. Immediate contact skin reactions, an update of contact urticaria, contact urticaria syndrome and protein contact dermatitis- "a never ending story". Eur J Dermatol 2010 ; 20 : 552-62.
PubMed
2) Yamakawa Y, Ohsuna H, Aihara M, et al. Contact urticaria from rice. Contact Dermatitis 2001 ; 44 : 91-3.
PubMed
3) Inomata N, Morita A, Sawaki H, et al. Case of rice allergy induced by epicutaneous sensitization with rice bran due to the handling rice-bran pickles. J Dermatol 2012 ; 39 : 1079-80.
 
4) Johansson J, Lahti A. Topical non-steroidal anti-inflammatory drugs inhibit nonimmunological immediate contact reactions. Contact Dermatitis 1988 ; 19 : 161-5.
 
5) Morrow JD, Minton TA, Awad JA, et al. Release of markedly increased quantities of prostaglandin D2 from the skin in vivo in humans following the application of sorbic acid. Arch Dermatol 1994 ; 130 : 1408-12.
PubMed
6) Downard CD, Roberts LJ, Morrow JD. Topical benzoic acid induces the increased synthesis of prostaglandin D2 in humans skin in vivo. Clin Pharmacol Ther 1995 ; 74 : 441-5.
 
7) Fukutomi Y, Itagaki Y, Taniguchi M, et al. Rhinoconjunctival sensitization to hydrolyzed wheat protein in facial soap can induce wheat-dependent exercise-induced anaphylaxis. J Allergy Clin Immunol 2011 ; 127 : 531-3.
PubMed
8) 平郡真記子, 石井香, 平郡隆明, ほか. 加水分解コムギ含有石鹸の使用後に発症した小麦依存性運動誘発アナフィラキシーとその経過について. アレルギー 2011 ; 60 : 1630-40.
Medical*Online
9) Amaro C, Goossens A. Immunological occupational contact urticaria and contact dermatitis from proteins : a review. Contact Dermatitis 2008 ; 58 : 67-75.
PubMed
10) Estlander T, Kanerva L, Tupasela O, et al. Immediate and delayed allergy to nickel with contact urticaria, rhinitis, asthma and contact dermatitis. Clin Exp Allergy 1993 ; 23 : 306.
PubMed
11) Babilas P, Landthaler M, Szeimies RM. Anaphylactic reaction following hair bleaching. Hautarzt 2005 ; 56 : 1152-5.
PubMed
12) Hjorth N, Roed-Petersen J. Occupational protein contact dermatitis in food handlers. Contact Dermatitis 1976 ; 2 : 28-42.
PubMed
13) Conde-Salazar L, Gonzalez MA, Guimaraens D. Type I and Type IV sensitization to Anisakis simplex in 2 patients with hand eczema. Contact Dermatitis 2002 ; 46 : 361.
PubMed
P.260 掲載の参考文献
1) Valsecchi R, Santini M, Leghissa P. Contact urticaria and asthma from Sarcophaga carnaria. Contact Dermatitis 2009 ; 61 : 186-7.
PubMed
2) 矢上晶子, 松永佳世子. ラテックスアレルギーの検査と診断. 松永佳世子, 編. Visual Dermatology別冊 : ラテックスアレルギーのすべて. 東京 : 秀潤社 ; 2007, pp50-7.
 
3) 矢上晶子, 松永佳世子. ラテックスアレルギーの治療と患者への生活指導. 松永佳世子, 編. Visual Dermatology別冊 : ラテックスアレルギーのすべて. 東京 : 秀潤社 ; 2007, pp58-61.
 

IV 血管性浮腫の病型 ( 各論 )

P.264 掲載の参考文献
1) Kim KM, Park CS, Kim TB, et al. A variant of idiopathic angioedema presenting as persistent facial swelling over 1 year. Allergy 2008 ; 63 : 378-9.
PubMed
2) 江畑俊哉. クインケ浮腫 (血管性浮腫). アレルギー・免疫 2003 ; 10 : 614-9.
 
3) 原田晋. 深部浮腫を伴う蕁麻疹への対応. MB Derma 2005 ; 105 : 66-73.
 
4) Frigas E, Park M. Idiopathic recurrent angioedema. Immunol Allergy Clin North Am 2006 ; 26 : 739-51.
PubMed
5) Zingale LC, Beltrami L, Zanichelli A, et al. Angioedema without urticaria : a large clinical survey. CMAJ 2006 ; 175 : 1065-70.
PubMed
6) 秀道広, 森田栄伸, 古川福実, ほか. 蕁麻疹診療ガイドライン. 日皮会誌 2011 ; 121 : 1339-88.
 
7) Munch EP, Weeke B. Non-hereditary angioedema treated with tranexamic acid. A 6-month placebo controlled trial with follow-up 4 years later. Allergy 1985 ; 40 : 92-7.
PubMed
8) Sands MF, Blume JW, Schwartz SA. Successful treatment of 3 patients with recurrent idiopathic angioedema with omalizumab. J Allergy Clin Immunol 2007 ; 120 : 979-81.
PubMed
9) Ghazan-Shahi S, Ellis AK. Severe steroid-dependent idiopathic angioedema with response to rituximab. Ann Allergy Asthma Immunol 2011 ; 107 : 374-6.
PubMed
P.267 掲載の参考文献
1) Sarkar P, Nicholson G, Hall G. Brief review : angiotensin converting enzyme inhibitors and angioedema : anesthetic implications. Can J Anesth 2006 ; 53 : 994-1003.
PubMed
2) 岩本和真, 三原祥嗣, 池澤善郎, ほか. 遺伝性血管性浮腫の全国実態調査. アレルギー 2011 ; 1 : 26-32.
Medical*Online
3) Hostis JB, Kim HJ, Rusnak J, et al. Incidence and characteristics of angioedema associated with enalapril. Arch Intern Med 2005 ; 165 : 1637-42.
 
4) 松尾佳美, 原武, 波多野裕二, ほか. アンジオテンシン変換酵素阻害薬による血管性浮腫の2例. 皮膚臨床 2011 ; 53 : 526-7.
 
5) Adam A, Cugno M, Molinaro G, et al. Aminopeptidase P in individuals with a history of angio-oedema on ACE inhibitors. Lancet 2002 ; 359 : 2088-9.
PubMed
6) Bas M, Hoffmann TK, Bier H, et al. Increased C-reactive protein in ACE-inhibitorinduced angioedema. Br J Clin Pharmacol 2004 ; 59 : 233-8.
 
7) Alexander G, Edward J, Ziad E, et al. Angioedema associated with angiotensin II receptor antagonists : challenging our knowledge of angioedema and its etiology. Laryngoscope 2001 ; 111 : 1729-31.
 
8) Haymore BR, Yoon J, Mikita CP, et al. Risk of angioedema with angiotensin receptor blockers in patients with prior angioedema associated with angiotensin-converting enzyme inhibitors : a meta-analysis. Ann Allergy Asthma Immunol 2008 ; 101 : 495-9.
PubMed
9) Bas M, Greve J, Stelter K, et al. Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors : a case series. Ann Emerg Med 2010 ; 56 : 278-82.
PubMed
P.270 掲載の参考文献
1) Kaplan AP, Greaves MW. Angioedema. J Am Acad Dermatol 2005 ; 53 : 373-88.
PubMed
2) D'Incan M, Tridon A, Ponard D, et al. Acquired angioedema with C1 inhibitor deficiensy : Is the distinction between type I and type II still relevant? Dermatology 1999 ; 199 : 227-30.
PubMed
3) Markovic SN, Inwards DJ, Frigas EA, et al. Acquired C1 esterase inhibitor deficiency. Ann Intern Med 2000 ; 132 : 144-50.
PubMed
4) Caballero T, Baeza ML, Cabanas R, et al. Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part I. Classification, epidemiology, pathophysiology, genetics, clinical symptoms, and diagnosis. J Investig Allergol Clin Immunol 2011 ; 21 : 333-47.
PubMed
5) Wasserfallen JB, Spaeth P, Guillou L, et al. Acquired deficiency in C1-inhibitor associated with signet ring cell gastric adenocarcinoma : a probable connection of antitumor-associated antibodies, hemolytic anemia, and complement turnover. J Allergy Clin Immunol 1995 ; 95 : 124-31.
PubMed
6) 工藤恵理奈, 梶原一亨, 木藤正人, ほか. 後天性C1エステラーゼインヒビター (C1-INH) 欠損性血管性浮腫. 皮膚病診療 2009 ; 31 : 53-6.
 
7) Caballero T, Baeza ML, Cabanas R, et al. Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part II. Treatment, follow-up, and special situations. J Investig Allergol Clin Immunol 2011 ; 21 : 422-41.
PubMed
8) Higa S, Hirata H, Minami S, et al. Autoimmune acquired form of angioedema that responded to danazol therapy. Intern Med 2002 ; 41 : 398-402.
PubMed
P.273 掲載の参考文献
1) Bracho FA. Hereditary angioedema. Curr Opin Hematol 2005 ; 12 : 493-8.
PubMed
2) Sachse MM, Khachemoune A, Guldbakke KK, et al. Hereditary angioedema. J Drugs Dermatol 2006 ; 5 : 848-52.
PubMed
3) Visy B, Fust G, Bygum A, et al. Helicobacter pylori infection as a triggering factor of attacks in patients with hereditary angioedema. Helicobacter 2007 ; 12 : 251-7.
PubMed
4) Schneider L, Lumry W, Vegh A, et al. Critical role of kallikrein in hereditary angioedema pathogenesis : a clinical trial of ecallantide, a novel kallikrein inhibitor. J Allergy Clin Immunol 2007 ; 120 : 416-22.
PubMed
5) 原田晋. 深部浮腫を伴う蕁麻疹への対応. MB Derma 2005 ; 105 : 66-73.
 
6) Verdi M, Shaker M. An update on hereditary angioedema. Adv Emerg Nurs 2011 ; 33 : 163-78.
PubMed
7) Johnston DT. Diagnosis and management of hereditary angioedema. J Am Osteopath Assoc 2011 ; 111 : 28-36.
PubMed
8) Weis M. Clinical review of hereditary angioedema : diagnosis and management. Postgrad Med 2009 ; 121 : 113-20.
PubMed
9) Zuraw BL, Christiansen SC. Pathogenesis and laboratory diagnosis of hereditary angioedema. Allergy Asthma Proc 2009 ; 30 : 487-92.
PubMed
10) Bork K, Meng G, Staubach P, et al. Hereditary angioedema : new findings concerning symptoms, affected organs, and course. Am J Med 2006 ; 119 : 267-74.
PubMed
11) Parish LC. Hereditary angioedema : diagnosis and management-a perspective for the dermatologist. J Am Acad Dermatol 2011 ; 65 : 843-50.
PubMed
12) Maurer M, Mageri M. Hereditary angioedema : an update on available therapeutic options. J Dtsch Dermatol Ges 2010 ; 8 : 663-72.
 
13) Zuraw BL. Hereditary angioedema : a current state-of-the-art review, IV : shortand long-term treatment of hereditary angioedema : out with the old and in with the new? Ann Allergy Asthma Immunol 2008 ; 100 (Suppl 2) : S13-8.
 
14) Prematta MJ, Prematta T, Craig T. Treatment of hereditary angioedema with plasma-derived C1 inhibitor. Ther Clin Risk Manag 2008 ; 4 : 1-8.
 
15) Zuraw BL, Christiansen SC. New promise and hope for treating hereditary angioedema. Expert Opin Investig Drugs 2008 ; 17 : 697-706.
PubMed
16) 原田晋. 遺伝性血管性浮腫 (HAE). 臨皮 2011 ; 65 (増刊) : 25-9.
 
17) Bernstein JA. Hereditary angioedema : a current state-of-the art review, VIII : current status of emerging therapies. Ann Allergy Asthma Immunol 2008 ; 100 (Suppl 2) : S41-6.
 
18) Frank MM, Jiang H. New therapies for hereditary angioedema : disease outlook changes dramatically. J Allergy Clin Immunol 2008 ; 121 : 272-80.
PubMed
19) Zuraw BL. Hereditary angioedema. N Engl J Med 2008 ; 359 : 1027-36.
PubMed
P.277 掲載の参考文献
1) Gompels MM, Lock RJ. C1 inhibitor deficiency : diagnosis. Clin Exp Dermatol 2005 ; 30 : 460-2.
PubMed
2) Bork K. Diagnosis and treatment of hereditary angioedema with normal C1 inhibitor. Allergy Asthma Clin Immunol 2010 ; 6 : 15.
PubMed
3) Cugno M, Zanichelli A, Bellatorre AG, et al. Plasma biomarkers of acute attacks in patients with angioedema due to C1-inhibitor deficiency. Allergy 2009 ; 64 : 254-7.
PubMed
4) Iwamoto K, Tanaka A, Kawai M, et al. A large heterozygous deletion including the entire C1 inhibitor gene in a sporadic case of hereditary angio-oedema. Clin Exp Dermatol 2012 ; 37 : 20-3.
 
5) Iwamoto K, Tanaka A, Hiragun M, et al. Novel and recurrent C1 inhibitor gene mutations in nine Japanese patients with hereditary angioedema. J Dermatol Sci 2012 ; 68 : 68-70.
PubMed
6) Kalmar L, Hegedus T, Farkas H, et al. HAEdb : a novel interactive, locus-specific mutation database for the C1 inhibitor gene. Hum Mutat 2005 ; 25 : 1-5.
PubMed
7) Pappalardo E, Cicardi M, Duponchel C, et al. Frequent de novo mutations and exon deletions in the C1 inhibitor gene of patients with angioedema. J Allergy Clin Immunol 2000 ; 106 : 1147-54.
PubMed
8) Yamamoto T, Horiuchi T, Miyahara H, et al. Hereditary angioedema in Japan : genetic analysis of 13 unrelated cases. Am J Med Sci 2012 ; 343 : 210-4.
PubMed
P.280 掲載の参考文献
1) Gleich GJ, Schroeter AL, Marcoux JP, et al. Episodic angioedema associated with eosinophilia. N Engl J Med 1984 ; 310 : 1621-6.
PubMed
2) Chikama R, Hosokawa M, Miyazawa T, et al. Nonepisodic angioedema associated with eosinophilia : report of 4 cases and review of 33 young female patients reported in Japan. Dermatology 1998 ; 197 : 321-5.
PubMed
3) 端本宇志, 田中智子, 高山かおる, ほか. 無治療で自然経過を観察したnon-episodic angioedema with eosinophilia : 本邦報告60例についての治療効果の統計と検討. 日皮会誌 2008 ; 118 : 925-31.
 
4) 原洋子, 井上千津子. Episodic angioedema accociated with eosinophilia の2例. 臨皮 1994 ; 48 : 367-70.
 
5) 渡部秀憲, 加藤聖, 溝口昌子. Episodic angioedema associated with eosinophiliaの1例. 皮膚臨床 2000 ; 42 : 113-5.
 
6) Butterfield JH, Leiferman KM, Abrams J, et al. Elevated serum levels of interleukin-5 in patients with the syndrome of episodic angioedema and eosinophilia. Blood 1992 ; 79 : 688-92.
PubMed
7) Collins PD, Marleau S, Griffiths-Johnson DA, et al. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med 1995 ; 182 : 1169-74.
PubMed
8) Wolf C, Pehamberger H, Breyer S, et al. Episodic angioedema with eosinophilia. J Am Acad Dermatol 1989 ; 20 : 21-7.
PubMed
9) Putterman C, Barak V, Caraco Y, et al. Episodic angioedema with eosinophilia : a case associated with T cell activation and cytokine production. Ann Allergy 1993 ; 70 : 243-8.
 
10) Mizukawa Y, Shiohara T. The cytokine profile in a transient variant of angioedema with eosinophilia. Br J Dermatol 2001 ; 144 : 169-74.
 
11) Okamoto H, Kamatani N. Plasma concentration of TARC/CCL17 is elevated in nonepisodic angioedema associated with eosinophilia. Allergy 2005 ; 60 : 1091-2.
PubMed
12) Yokobayashi H, Sugaya M, Miyagaki T, et al. Serum chemokine levels in a case of angio-oedema associated with eosinophilia. Br J Dermatol 2008 ; 159 : 738-40.
 

V 蕁麻疹の類症

P.284 掲載の参考文献
1) 川名誠司. 蕁麻疹様紅斑. 皮膚病診療 1998 ; 20 : 105-10.
 
2) 川名誠司, 西岡清, 西山茂夫. 好中球優位の細胞浸潤を伴う蕁麻疹様紅斑-Urticarial vasculitisの位置づけ. 日皮会誌 1991 ; 101 : 951-7.
 
3) Wisnieski JJ. Urticarial vasculitis. Curr Opin Rheumatol 2000 ; 12 : 24-31.
PubMed
4) Schwartz HR, McDuffie FC, Black LF, et al. Hypocomplementemic urticarial vasculitis : association with chronic obstructive pulmonary disease. Mayo Clin Proc 1982 ; 57 : 231-8.
PubMed
5) Kawana S, Ohta M, Nishiyama S. Value of the assay for IgA-containing circulating immune complexes in Henoch-Schonlein purpura. Dermatologica 1986 ; 172 : 245-53.
PubMed
6) Kato Y, Aoki M, Kawana S. Urticarial vasculitis appearing in the progression of systemic sclerosis. J Dermatol 2006 ; 33 : 792-7.
PubMed
7) Mannik M, Wener MH. Deposition of antibodies to the collagen-like region of C1q in renal glomeruli of patients with proliferative lupus glomerulonephritis. Arthritis Rheum 1997 ; 40 : 1504-11.
 
8) Sinico RA, Rimoldi L, Radice A, et al. Anti-C1q autoantibodies in lupus nephritis. Ann N Y Acad Sci 2009 ; 1173 : 47-51.
PubMed
9) Bisaccia E, Adamo V, Rozan SW. Urticarial vasculitis progressing to systemic lupus erythematosus. Arch Dermatol 1988 ; 124 : 1088-90.
PubMed
10) Aydogan K, Karadogan SK, Adim SB, et al. Hypocomplementemic urticarial vasculitis : a rare presentation of systemic lupus erythematosus. Int J Dermatol 2006 ; 45 : 1057-61.
PubMed
11) Soma J, Sato H, Ito S, et al. Nephrotic syndrome associated with hypocomplementaemic urticarial vasculitis syndrome : successful treatment with cyclosporin A. Nephrol Dial Transplant 1999 ; 14 : 1753-7.
PubMed
12) Alexander JL, Kalaaji AN, Shehan JM, et al. Plasmapheresis for refractory urticarial vasculitis in a patient with B-cell chronic lymphocytic leukemia. J Drug Dermatol 2006 ; 5 : 534-7.
 
13) Yamazaki-Nakashimada MA, Duran-McKinster C, Ramirez-Vargas N, et al. Intravenous immunoglobulin therapy for hypocomplementemic urticarial vasculitis associated with systemic lupus erythematosus in a child. Pediatr Dermatol 2009 ; 26 : 445-7.
 
14) Saigal K, Valencia IC, Cohen J, et al. Hypocomplementemic urticarial vasculitis with angioedema, a rare presentation of systemic lupus erythematosus : rapid response to rituximab. J Am Acad Dermatol 2003 ; 49 : S283-5.
PubMed
P.289 掲載の参考文献
1) Valent P, Akin C, Sperr WR, et al. Mastocytosis : pathology, genetics, and current options for therapy. Leuk Lymphoma 2005 ; 46 : 35-48.
PubMed
2) 宮川 (林野) 文. 肥満細胞症. 真鍋俊明, ほか編. 腫瘍病理鑑別診断アトラス 皮膚腫瘍 II. メラノサイト系腫瘍とリンパ・組織球・造血系腫瘍. 東京 : 文光堂 ; 2010. pp137-9.
 
3) 出光俊郎, 加倉井真樹. 肥満細胞症. MB Derma 2006 ; 120 : 76-83.
 
4) 江川裕美, 神戸直智, 谷岡未樹, ほか. 成人肥満細胞症の1例 : 1995年以降の本邦報告例36例についての臨床統計を含めて. 臨皮 2007 ; 61 : 11-4.
 
5) 出光俊郎, 井上多恵. 肥満細胞症 (肥満細胞腫). 玉置邦彦, ほか編. 最新皮膚科学大系 13. 神経系腫瘍 間葉系腫瘍. 東京 : 中山書店 ; 2002. pp341-54.
 
6) Ben-Amitai D, Metzker A, Cohen HA. Pediatric cutaneous mastocytosis : a review of 180 patients. Isr Med Assoc J 2005 ; 7 : 320-2.
PubMed
7) 柳堀浩克. マストサイトーシス. 皮膚アレルギーフロンティア 2007 ; 5 : 17-20.
Medical*Online
8) Carter MC, Metcalfe DD. In : Wolff K, et al. editors. Fitzpatric's Dermatology in General Medicine. 7th ed. New York : McGraw-Hill ; 2007, pp1440.
 
9) 小沢桂, 菊池智, 折笠玲子, ほか. 肥満細胞症の3例. 日皮会誌 2005 ; 115 : 1023-8.
 
P.292 掲載の参考文献
1) 菅野重, 森田明理, 辻卓夫. 皮膚肥満細胞症に対する各種薬剤投与後のDarier徴候の抑制の比較. 西日皮膚 2000 ; 62 : 349-52.
 
2) 江川裕美, 神戸直智, 谷岡未樹, ほか. 成人肥満細胞症の1例 : 1995年以降の本邦報告例36例についての臨床統計を含めて. 臨皮 2007 ; 61 : 11-4.
 
3) Ben-Amitai D, Metzker A, Cohen HA. Pediatric cutaneous mastocytosis : a review of 180 patients. Isr Med Assoc J 2005 ; 7 : 320-2.
PubMed
4) Vella Briffa D, Eady RA, James MP, et al. Photochemotherapy (PUVA) in the treatment of urticaria pigmentosa. Br J Dermatol 1983 ; 109 : 67-75.
PubMed
5) Stege H, Schopf E, Ruzicka T, et al. High-dose UVA1 for urticaria pigmentosa. Lancet 1996 ; 347 : 64.
PubMed
6) 出光俊郎, 加倉井真樹. 肥満細胞症. MB Derma 2006 ; 120 : 76-83.
 
P.295 掲載の参考文献
1) Schnitzler L. Lesion urticariennes chroniques permanents (erytheme petaloide?). Case cliniques n. 46B. J Dermatol Angers 1972 ; 28 (Abstr. 46).
 
2) 調裕次, 高木圭一, 川津智是, ほか. Schnitzler's syndromeの1例. 日皮会誌 2001 ; 111 : 947-53.
 
3) De Castro FR, Masouye I, Winklemann RK, et al. Urticarial pathology in Schnitzler's (hyper IgM) syndrome. Dermatology 1996 ; 193 : 94-9.
 
4) Nashan D, Sunderkotter C, Bonsmann G, et al. Chronic urticaria, arthralgia, raised erythrocyte sedimentation rate and IgG paraproteinaemia : a variant of Schnitzler's syndrome? Br J Dermatol 1995 ; 133 : 132-4.
 
5) Akimoto R, Yoshida M, Matsuda R, et al. Schnitzler's syndrome with IgG κ gammopathy. J Dermatol 2002 ; 29 : 735-38.
 
6) Lipsker D, Veran Y, Grunenberger F, et al. The Schnitzler syndrome : four new cases and review of the literature. Medicine 2001 ; 80 : 37-44.
PubMed
7) 末次香織, 大久保ゆかり, 瀬戸山充, ほか. Schnitzler症候群-bath-PUVA療法が有効であった例. 皮膚病診療 2010 ; 32 : 419-22.
 
8) Tinazzi E, Puccetti A, Patuzzo G, et al. Schnitzler syndrome, an autoimmune-autoinflammatory syndrome : report of two new cases and review of the literature. Autoimmun Rev 2011 ; 10 : 404-9.
PubMed
9) Gran JT, Midtvedt O, Haug S, et al. Treatment of Schnitzler's syndrome with anakinra : report of three cases and review of the literature. Scand J Rheumatol 2011 ; 40 : 74-9.
 
P.298 掲載の参考文献
1) Hoffman HM, Mueller JL, Broide DH, et al. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 2001 ; 29 : 301-5.
PubMed
2) Feldmann J, Prieur AM, Quartier P, et al. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am J Hum Genet 2002 ; 71 : 198-203.
PubMed
3) Neven B, Prieur AM, Quartier dit Maire P. Cryopyrinopathies : update on pathogenesis and treatment. Nat Clin Pract Rheumatol 2008 ; 4 : 481-9.
PubMed
4) Saito M, Nishikomori R, Kambe N, et al. Disease-associated CIAS1 mutations induce monocyte death, revealing low-level mosaicism in mutation-negative cryopyrin-associated periodic syndrome patients. Blood 2008 ; 111 : 2132-41.
PubMed
5) Tanaka N, Izawa K, Saito MK, et al. High incidence of NLRP3 somatic mosaicism in chronic infantile neurological cutaneous and articular syndrome patients : the results of an international multicenter collaborative study. Arthritis Rheum 2011 ; 63 : 3635-32.
 
6) 佐藤貴史, 神戸直智. 自己炎症性疾患に対する抗体療法. 医学のあゆみ 2011 ; 238 : 724-9.
Medical*Online
7) Neven B, Callebaut I, Prieur AM, et al. Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU. Blood 2004 ; 103 : 2809-15.
PubMed
8) Muckle TJ, Wells M. Urticaria, deafness, and amyloidosis : a new heredo-familial syndrome. Q J Med 1962 ; 31 : 235-48.
 
9) 玉置邦彦, 吉田実夫, 中村康青. Muckle-wells Syndrome. 皮膚臨床 1976 ; 18 : 293-303.
 
10) Nakamura Y, Kambe N, Saito M, et al. Mast cells mediate neutrophil recruitment and vascular leakage through the NLRP3 inflammasome in histamine-independent urticaria. J Exp Med 2009 ; 206 : 1037-46.
PubMed
P.303 掲載の参考文献
1) Saito M, Fujisawa A, Nishikomori R, et al. Somatic mosaicism of CIAS1 in a patient with chronic infantile neurologic, cutaneous, articular syndrome. Arthritis Rheum 2005 ; 52 : 3579-85.
 
2) Tanaka N, Izawa K, Saito MK, et al. High incidence of NLRP3 somatic mosaicism in patients with chronic infantile neurologic, cutaneous, articular syndrome : results of an international multicenter collaborative study. Arthritis Rheum 2011 ; 63 : 3625-32.
PubMed
3) Goldbach-Mansky R, Dailey NJ, Canna SW, et al. Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N Engl J Med 2006 ; 355 : 581-92.
PubMed
4) Lachmann HJ, Kone-Paut I, Kuemmerle-Deschner JB, et al. Use of canakinumab in the cryopyrin-associated periodic syndrome. N Engl J Med 2009 ; 360 : 2416-25.
PubMed
P.306 掲載の参考文献
1) 古江増隆, 佐伯秀久, 古川福実, ほか. アトピー性皮膚炎診療ガイドライン. 日皮会誌 2009 ; 119 : 1515-34.
 
2) 秀道広, 森田栄伸, 古川福実, ほか. 蕁麻疹診療ガイドライン. 日皮会誌 2011 ; 121 : 1339-88.
 
3) Johansson SG, Hourihane JO, Bousquet J, et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001 ; 56 : 813-24.
 
4) Holgate ST. The epithelium takes centre stage in asthma and atopic dermatitis. Trends Immunol 2007 ; 28 : 248-51.
PubMed
5) Katayama I, Bae SJ, Hamasaki Y, et al. Stress response, tachykinin and cutaneous inflammation. J Investig Dermatol Symp Proc 2001 ; 6 : 81-6.
PubMed
6) Bae S, Matsunaga Y, Tanaka Y, et al. Autocrine induction of substance P mRNA and peptide in cultured normal human keratinocytes. Biochem Biophys Res Commun 1999 ; 263 : 327-33.
PubMed
7) Nishioka K, Katayama I, Doi T. Histamine release by scratching inflamed skin. J Dermatol 1987 ; 14 : 284-5.
PubMed
8) Matsunaga T, Katayama I, Yokozeki H, et al. ICAM-1 expression on keratinocytes in mechanically-injured skin of a patient with atopic dermatitis. J Dermatol Sci 1996 ; 12 : 219-26.
PubMed
9) 片山一朗. アトピー性皮膚炎・キーワードとその考え方 (2) 皮膚のバリアー機能 : 非免疫学的側面から見たアトピー性皮膚炎. 西日皮膚 1998 ; 60 : 674-80.
 
10) Elias PM, Steinhoff M. "Outside-to-inside" (and now back to "outside") pathogenic mechanisms in atopic dermatitis. J Invest Dermatol 2008 ; 128 : 1067-70.
PubMed
11) Hata D, Kawakami Y, Inagaki N, et al. Involvement of Bruton's tyrosine kinase in FcεRI-dependent mast cell degranulation and cytokine production. J Exp Med 1998 ; 187 : 1235-47.
 
12) Hitomi K, Tahara-Hanaoka S, Someya S, et al. An immunoglobulin-like receptor, Allergin-1, inhibits immunoglobulin E-mediated immediate hypersensitivity reactions. Nat Immunol 2010 ; 11 : 601-7.
PubMed
13) Katoh N, Hirano S, Suehiro M, et al. The characteristics of patients with atopic dermatitis demonstrating a positive reaction in a scratch test after 48 hours against house dust mite antigen. J Dermatol 2004 ; 31 : 720-6.
 
14) Mukai K, Matsuoka K, Taya C, et al. Basophils play a critical role in the development of IgE-mediated chronic allergic inflammation independently of T cells and mast cells. Immunity 2005 ; 23 : 191-202.
PubMed
15) Katayama I, Tanei R, Yokozeki H, et al. Induction of eczematous skin reaction in experimentally induced hyperplastic skin of Balb/C mice by monoclonal anti-DNP IgE antibody : possible implications for skin lesion formation in atopic dermatitis. Int Arch Allergy Appl Immunol 1990 ; 93 : 148-54.
PubMed
16) Oiwa M, Satoh T, Watanabe M, et al. CRTH2-dependent, STAT6-independent induction of cedar pollen dermatitis. Clin Exp Allergy 2008 ; 38 : 1357-66.
PubMed
17) Kamijo S, Takai T, Kuhara T, et al. Cupressaceae pollen grains modulate dendritic cell response and exhibit IgE-inducing adjuvant activity in vivo. J Immunol 2009 ; 183 : 6087-94.
PubMed
18) Takeda T, Sakurai Y, Takahagi S, et al. Increase of coagulation potential in chronic spontaneous urticaria. Allergy 2011 ; 66 : 428-33.
PubMed
19) Cugno M, Marzano AV, Asero R, et al. Activation of blood coagulation in chronic urticaria : pathophysiological and clinical implications. Intern Emerg Med 2009 ; 5 : 97-101.
PubMed
20) Tamagawa-Mineoka R, Katoh N, Ueda E, et al. Elevated platelet activation in patients with atopic dermatitis and psoriasis : increased plasma levels of betathromboglobulin and platelet factor 4. Allergol Int 2008 ; 57 : 391-6.
PubMed
21) Hide M, Francis DM, Grattan CE, et al. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993 ; 328 : 1599-604.
PubMed
22) Nawata Y, Koike T, Hosokawa H, et al. Anti-IgE autoantibody in patients with atopic dermatitis. J Immunol 1985 ; 135 : 478-82.
PubMed
23) Takahagi S, Tanaka T, Ishii K, et al. Sweat antigen induces histamine release from basophils of patients with cholinergic urticaria associated with atopic diathesis. Br J Dermatol 2009 ; 160 : 426-8.
PubMed
24) Shindo H, Ishii K, Yanase Y, et al. Histamine release-neutralization assay for sera of patients with atopic dermatitis and/or cholinergic urticaria is useful to screen type I hypersensitivity against sweat antigens. Arch Dermatol Res 2012 ; 304 : 647-54.
PubMed
25) Eishi K, Lee JB, Bae SJ, et al. Impaired sweating function in adult atopic dermatitis : results of the quantitative sudomotor axon reflex test. Br J Dermatol 2002 ; 147 : 683-8.
PubMed
26) Murota H, Katayama I. Assessment of antihistamines in the treatment of skin allergies. Curr Opin Allergy Clin Immunol 2011 ; 11 : 428-37.
PubMed

書評

最近チェックした商品履歴

Loading...